10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244

VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	11-2989601
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
Terminal Drive Plainview, New York	11803
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:

(516) 677-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	VECO	The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes ☒  No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

As of October 27, 2021, there were 50,503,953 shares of the registrant’s common stock outstanding.

VEECO INSTRUMENTS INC.

INDEX

Safe Harbor Statement	1
PART I—FINANCIAL INFORMATION	4
Item 1. Financial Statements	4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3. Quantitative and Qualitative Disclosures about Market Risk	37
Item 4. Controls and Procedures	38
PART II—OTHER INFORMATION	38
Item 1. Legal Proceedings	38
Item 1A. Risk Factors	39
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 3. Defaults Upon Senior Securities	39
Item 4. Mine Safety Disclosures	39
Item 5. Other Information	39
Item 6. Exhibits	40
SIGNATURES	41

Safe Harbor Statement

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results.

In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events, including the potential impact of the COVID-19 pandemic on our business, and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions.

The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, those set forth under the heading “Risk Factors” Part 1, Item 1A in our 2020 Form 10-K, and the following:

Risks Related to Our Business, Finance and Operations

● The effects of the COVID-19 pandemic have strained and have threatened to negatively impact our businesses and operations, and the duration and extent to which COVID-19 may impact our future results of operations and overall financial performance remains uncertain;

● Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results;

● The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

● Our sales cycle is long and unpredictable;

● Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed;

● We may be required to take impairment charges on assets;

● We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures;

● We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;

● We may not have the ability to raise the funds necessary to settle for cash conversions of our 2.70% Convertible Senior Notes due 2023 (the “2023 Notes”), our 3.50% Convertible Senior Notes due 2025 (the “2025 Notes”), or our 3.75% Convertible Senior Notes due 2027 (the “2027 Notes”) (the 2023 Notes, 2025 Notes, and 2027 Notes, together, the “Notes”) or to repurchase the Notes for cash upon a fundamental change, and any future debt may contain limitations on our ability to pay cash upon conversion or repurchase of the Notes;

1

● The conditional conversion features of the 2023 Notes, 2025 Notes, and 2027 Notes, if triggered, may materially and adversely affect our financial condition and operating results;

● The accounting method for convertible debt securities that may be settled in cash, such as the Notes, could have a material effect on our reported financial results;

● Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our net operating loss carryforwards or our research and development credits carryforwards in the future;

● The capped call transactions may affect the value of the 2027 Notes and our common stock;

Risks Associated with Operating a Global Business

● We are exposed to risks of operating businesses outside the United States;

● Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition;

● We may be unable to obtain required export licenses for the sale of our products;

● We are exposed to various risks associated with global regulatory requirements;

● We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws;

● Our operating results may be adversely affected by tightening credit markets;

● We are subject to foreign currency exchange risks;

Risks Related to Intellectual Property and Cybersecurity

● Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us;

● We may be unable to effectively enforce and protect our intellectual property rights;

● We may be subject to claims of intellectual property infringement by others;

Risks Associated with Our Industry

● We face significant competition;

● We operate in industries characterized by rapid technological change;

● Certain of our sales are dependent on the demand for consumer electronics, which can experience significant volatility due to seasonal and other factors;

● We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries;

● The cyclicality of the industries we serve directly affects our business;

2

● Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand;

● Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations;

● We rely on a limited number of suppliers, some of whom are our sole source for particular components;

General Risk Factors

● The price of our common shares is volatile and could decrease;

● We are subject to risks of non-compliance with environmental, health, and safety regulations;

● Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;

● Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results; and

● Our income taxes may change.

Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements.

3

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

	September 30,		December 31,
	2021		2020
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	121,602	$	129,625
Restricted cash		629		658
Short-term investments		213,985		189,771
Accounts receivable, net		86,759		79,991
Contract assets		27,467		21,246
Inventories		170,835		145,906
Deferred cost of sales		635		433
Prepaid expenses and other current assets		31,592		19,301
Total current assets		653,504		586,931
Property, plant, and equipment, net		93,851		65,271
Operating lease right-of-use assets		26,481		10,275
Intangible assets, net		36,880		46,185
Goodwill		181,943		181,943
Deferred income taxes		1,440		1,440
Other assets		3,709		6,019
Total assets	$	997,808	$	898,064
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	48,749	$	33,656
Accrued expenses and other current liabilities		76,033		44,876
Customer deposits and deferred revenue		60,703		67,235
Income taxes payable		1,737		914
Total current liabilities		187,222		146,681
Deferred income taxes		5,228		5,240
Long-term debt		331,877		321,115
Long-term operating lease liabilities		30,325		6,305
Other liabilities		7,843		10,349
Total liabilities		562,495		489,690
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.		—		—
Common stock, $0.01 par value; 120,000,000 shares authorized; 50,321,048 shares issued and outstanding at September 30, 2021 and 49,723,751 shares issued and outstanding at December 31, 2020		503		497
Additional paid-in capital		1,122,526		1,113,352
Accumulated deficit		(689,486)		(707,321)
Accumulated other comprehensive income		1,770		1,846
Total stockholders' equity		435,313		408,374
Total liabilities and stockholders' equity	$	997,808	$	898,064

See accompanying Notes to the Consolidated Financial Statements.

4

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales	$	150,246	$	112,078	$	430,305	$	315,216
Cost of sales		87,077		62,936		252,055		177,761
Gross profit		63,169		49,142		178,250		137,455
Operating expenses, net:
Research and development		21,999		19,129		66,397		57,577
Selling, general, and administrative		21,603		19,415		63,325		55,541
Amortization of intangible assets		2,976		3,831		9,305		11,502
Restructuring		—		—		—		1,097
Asset impairment		—		—		—		281
Other operating expense (income), net		175		(218)		138		(502)
Total operating expenses, net		46,753		42,157		139,165		125,496
Operating income (loss)		16,416		6,985		39,085		11,959
Interest income		95		231		464		1,458
Interest expense		(7,107)		(6,425)		(20,685)		(18,131)
Loss on extinguishment of debt		—		—		—		(3,046)
Income (loss) before income taxes		9,404		791		18,864		(7,760)
Income tax expense (benefit)		411		211		1,029		530
Net income (loss)	$	8,993	$	580	$	17,835	$	(8,290)
Income (loss) per common share:
Basic	$	0.18	$	0.01	$	0.36	$	(0.17)
Diluted	$	0.17	$	0.01	$	0.33	$	(0.17)
Weighted average number of shares:
Basic		49,021		48,341		48,968		48,327
Diluted		53,849		49,174		53,606		48,327

See accompanying Notes to the Consolidated Financial Statements.

5

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

(unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net income (loss)	$	8,993	$	580	$	17,835	$	(8,290)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities		(12)		(69)		(16)		(16)
Change in currency translation adjustments		(21)		9		(60)		(21)
Total other comprehensive income (loss), net of tax		(33)		(60)		(76)		(37)
Total comprehensive income (loss)	$	8,960	$	520	$	17,759	$	(8,327)

See accompanying Notes to the Consolidated Financial Statements.

6

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Nine months ended September 30,
	2021		2020
Cash Flows from Operating Activities
Net income (loss)	$	17,835	$	(8,290)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		19,634		23,021
Non-cash interest expense		10,762		10,282
Deferred income taxes		(12)		330
Share-based compensation expense		11,735		9,562
Loss on extinguishment of debt		—		3,046
Asset impairment		—		281
Provision for bad debts		—		140
Changes in operating assets and liabilities:
Accounts receivable and contract assets		(12,987)		(30,677)
Inventories and deferred cost of sales		(24,879)		(10,336)
Prepaid expenses and other current assets		9,829		(982)
Accounts payable and accrued expenses		21,786		11,130
Customer deposits and deferred revenue		(6,532)		16,728
Income taxes receivable and payable, net		823		61
Other, net		2,655		3,295
Net cash provided by (used in) operating activities		50,649		27,591
Cash Flows from Investing Activities
Capital expenditures		(31,453)		(3,331)
Proceeds from the sale of investments		199,475		139,531
Payments for purchases of investments		(225,112)		(185,576)
Proceeds from held for sale assets, net of costs to sell		—		9,503
Net cash provided by (used in) investing activities		(57,090)		(39,873)
Cash Flows from Financing Activities
Proceeds from issuance of 2027 Notes, net of issuance costs		—		121,946
Purchase of capped calls		—		(10,313)
Repurchase of 2023 Notes		—		(81,240)
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan		2,709		2,428
Restricted stock tax withholdings		(4,260)		(2,217)
Net cash provided by (used in) financing activities		(1,551)		30,604
Effect of exchange rate changes on cash and cash equivalents		(60)		(21)
Net increase (decrease) in cash, cash equivalents, and restricted cash		(8,052)		18,301
Cash, cash equivalents, and restricted cash - beginning of period		130,283		129,951
Cash, cash equivalents, and restricted cash - end of period	$	122,231	$	148,252
Supplemental Disclosure of Cash Flow Information
Interest paid	$	9,039	$	8,989
Net income taxes paid (refunds received)		(130)		248
Non-cash activities
Capital expenditures included in accounts payable and accrued expenses		9,133		705
Net transfer of property, plant and equipment to inventory		253		1,624
Right-of-use assets obtained in exchange for lease obligations		20,353		951

See accompanying Notes to the Consolidated Financial Statements.

7

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

(unaudited)

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2021 interim quarters end on April 4, July 4, and October 3, and the 2020 interim quarters ended on March 29, June 28, and September 27. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

8

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

9

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

The Company adopted ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes in the second quarter of 2020, effective as of the beginning of fiscal year 2020. This ASU simplifies the accounting for income taxes by eliminating certain exceptions to the general principles and simplifying several aspects of ASC 740, Income Taxes, including, but not limited to, requirements related to the following: a) exception to the incremental approach for intraperiod tax allocation; b) the tax basis step-up in goodwill obtained in a transaction that is not a business combination; c) ownership changes in investments - changes from a subsidiary to an equity method investment; d) separate financial statements of entities not subject to tax; e) interim-period accounting for enacted changes in tax law; and f) the year-to-date loss limitation in interim-period tax accounting. The adoption did not have a material impact on the Company’s consolidated financial statements as of the date of adoption.

Recent Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021. The Company’s 2023 Notes, 2025 Notes, and 2027 Notes all are currently accounted for using the separation models for convertible debt with a cash conversion feature, and therefore upon adoption of ASU 2020-06 in the first quarter of 2022, the Company expects a decrease in non-cash interest expense. Additionally, the Company will be required to use the if-converted method for its current convertible debt when calculating diluted earnings (loss) per share, which will result in an increase in income available to common shareholders, as well as an increase in diluted shares outstanding. The Company expects to use the modified retrospective method of adoption.

i

10

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 2 — Income (Loss) Per Common Share

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income (loss) per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. The Company has determined that it has the ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock. As such, the Company accounts for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive. The computations of basic and diluted income (loss) per share for the three and nine months ended September 30, 2021 and 2020 are as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands, except per share amounts)
Net income (loss)	$	8,993	$	580	$	17,835	$	(8,290)
Net income (loss) per common share:
Basic	$	0.18	$	0.01	$	0.36	$	(0.17)
Diluted	$	0.17	$	0.01	$	0.33	$	(0.17)
Basic weighted average shares outstanding		49,021		48,341		48,968		48,327
Dilutive effect of share-based awards		1,507		833		1,377
Dilutive effect of the 2027 Notes		3,321		—		3,261		—
Diluted weighted average shares outstanding		53,849		49,174		53,606		48,327
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		N/A		N/A		N/A		650
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		451		984		447		1,029
Maximum potential shares to be issued for settlement of the 2023, 2025, and 2027 Notes excluded from the diluted calculation as their effect would be antidilutive due to a net loss or the fact that the conversion value of the Notes did not exceed their principal amount		8,811		15,354		8,811		15,354

Note 3 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

11

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2021
Cash equivalents
Certificate of deposits and time deposits	$	55,358	$	—	$	—	$	55,358
Corporate debt		—		—		—		—
Commercial paper		—		—		—		—
Money market cash		1,069		—		—		1,069
Total	$	56,427	$	—	$	—	$	56,427
Short-term investments
U.S. treasuries	$	118,782	$	—	$	—	$	118,782
Government agency securities		—		12,086		—		12,086
Corporate debt		—		67,678		—		67,678
Commercial paper		—		15,439		—		15,439
Total	$	118,782	$	95,203	$	—	$	213,985
December 31, 2020
Cash equivalents
Certificate of deposits and time deposits	$	59,168	$	—	$	—	$	59,168
Commercial paper		—		2,000		—		2,000
U.S. treasuries		24,997		—		—		24,997
Total	$	84,165	$	2,000	$	—	$	86,165
Short-term investments
U.S. treasuries	$	149,219	$	—	$	—	$	149,219
Corporate debt		—		32,554		—		32,554
Commercial paper		—		7,998		—		7,998
Total	$	149,219	$	40,552	$	—	$	189,771

12

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

There were no transfers between fair value measurement levels during the three and nine months ended September 30, 2021.

At September 30, 2021 and December 31, 2020, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2021
U.S. treasuries	$	118,801	$	9	$	(28)	$	118,782
Government agency securities		12,092		—		(6)		12,086
Corporate debt		67,689		28		(39)		67,678
Commercial paper		15,439		—		—		15,439
Total	$	214,021	$	37	$	(73)	$	213,985
December 31, 2020
U.S. treasuries	$	149,206	$	14	$	(1)	$	149,219
Corporate debt		32,588		—		(34)		32,554
Commercial paper		7,997		1		—		7,998
Total	$	189,791	$	15	$	(35)	$	189,771

Available-for-sale securities in a loss position at September 30, 2021 and December 31, 2020 consist of:

	September 30, 2021				December 31, 2020
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	64,093	$	(28)	$	19,991	$	(1)
Government agency securities		12,086		(6)		—		—
Corporate debt		39,549		(39)		32,554		(34)
Total	$	115,728	$	(73)	$	52,545	$	(35)

At September 30, 2021 and December 31, 2020, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The contractual maturities of securities classified as available-for-sale at September 30, 2021 were as follows:

	September 30, 2021
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	121,123	$	121,128
Due after one year through two years		87,080		87,037
Due after two years through three years		5,818		5,820
Total	$	214,021	$	213,985

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were minimal realized gains or losses for the nine months ended September 30, 2021 and no realized gains or losses for the nine months ended September 30, 2020.

13

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $0.7 million at September 30, 2021 and December 31, 2020. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts.

Inventories

Inventories at September 30, 2021 and December 31, 2020 consist of the following:

	September 30,		December 31,
	2021		2020
	(in thousands)
Materials	$	90,982	$	82,679
Work-in-process		64,134		53,979
Finished goods		15,719		9,248
Total	$	170,835	$	145,906

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. The balance as of September 30, 2021 includes a current receivable of $15.0 million for insurance recoveries related to the legal settlement referenced in Note 5, “Commitments and Contingencies,” as well as a current receivable of $1.1 million related to landlord reimbursement for leasehold improvements associated with the Company’s new leased facility in San Jose, California. In addition, Veeco had deposits with its suppliers of $4.2 million and $7.2 million at September 30, 2021 and December 31, 2020, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at September 30, 2021 and December 31, 2020 consist of the following:

	September 30,		December 31,
	2021		2020
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		63,944		62,865
Machinery and equipment (1)		144,937		140,493
Leasehold improvements		38,262		6,671
Gross property, plant, and equipment		252,204		215,090
Less: accumulated depreciation and amortization		158,353		149,819
Net property, plant, and equipment	$	93,851	$	65,271

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and nine months ended September 30, 2021, depreciation expense was $3.5 million and $10.3 million, respectively, and $3.8 million and $11.5 million, respectively, for the comparable 2020 periods.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The Company continues to assess potential triggering events related to

14

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

the value of its goodwill and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2021.

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2021.

The components of purchased intangible assets were as follows:

	September 30, 2021						December 31, 2020
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	308,587	$	19,321	$	327,908	$	302,358	$	25,550
Customer relationships		146,465		132,260		14,205		146,465		130,131		16,334
Trademarks and tradenames		30,910		27,556		3,354		30,910		26,614		4,296
Other		3,686		3,686		—		3,686		3,681		5
Total	$	508,969	$	472,089	$	36,880	$	508,969	$	462,784	$	46,185

Other intangible assets primarily consist of patents, licenses, and backlog.

Note 4 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at September 30, 2021 and December 31, 2020 consist of:

	September 30,		December 31,
	2021		2020
	(in thousands)
Payroll and related benefits	$	33,868	$	26,630
Warranty		6,544		5,058
Operating lease liabilities		4,162		4,148
Interest		3,459		2,574
Professional fees		1,140		1,112
Legal settlement		15,000		—
Sales, use, and other taxes		6,092		2,658
Other		5,768		2,696
Total	$	76,033	$	44,876

15

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the nine months ended September 30, 2021 include:

		(in thousands)
Balance - December 31, 2020	$	5,058
Warranties issued		4,766
Consumption of reserves		(4,401)
Changes in estimate		1,121
Balance - September 30, 2021	$	6,544

Customer Deposits and Deferred Revenue

Customer deposits totaled $44.6 million and $49.3 million at September 30, 2021 and December 31, 2020, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2020	$	17,985
Deferral of revenue		7,008
Recognition of unearned revenue		(8,913)
Balance - September 30, 2021	$	16,080

As of September 30, 2021, the Company has approximately $34.6 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 73% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately

16

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

$88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

The 2023 Notes, 2025 Notes, and 2027 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 24.9800, 41.6667, and 71.5372 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, representing initial effective conversion prices of $40.03, $24.00, and $13.98 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for

17

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended September 30, 2021, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until December 31, 2021.

Holders may convert their notes at any time, regardless of the foregoing circumstances, on or after October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, until the close of business on the business day immediately preceding the respective maturity date.

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion options, the Company segregated the liability component of the instruments from the equity components. The liability components were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Notes. The calculation of the fair value of the debt components required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Notes at a discount rate equal to the estimated borrowing rate for similar non-convertible debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face values of the Notes over the estimated fair values of the liability components of $72.5 million, $21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as debt discounts and recorded as an increase to additional paid-in capital and will be amortized over the expected lives of the Notes using the effective interest rate method. Amortization of the debt discounts are recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected terms of the Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity components recognized in stockholders' equity.

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call

18

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

The carrying value of the 2023 Notes, 2025 Notes and 2027 Notes are as follows:

		September 30, 2021						December 31, 2020
		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	131,695	$	(7,754)	$	123,941	$	131,695	$	(11,925)	$	119,770
2025 Notes		132,500		(18,539)		113,961		132,500		(22,097)		110,403
2027 Notes		125,000		(31,025)		93,975		125,000		(34,058)		90,942
Net carrying value	$	389,195	$	(57,318)	$	331,877	$	389,195	$	(68,080)	$	321,115

Total interest expense related to the 2023 Notes, 2025 Notes and 2027 Notes is as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	889	$	1,733	$	2,667	$	6,060
Coupon interest expense - 2025 Notes		1,159		—		3,478		—
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		1,745
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		1,417		2,563		4,171		8,887
Amortization of debt discount/transaction costs- 2025 Notes		1,211		—		3,558		—
Amortization of debt discount/transaction costs- 2027 Notes		1,035		941		3,033		1,395
Total Interest Expense	$	6,883	$	6,409	$	20,423	$	18,087

The Company determined the 2023 Notes, 2025 notes, and 2027 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at September 30, 2021 of $132.6 million, $158.2, and $223.9 million, respectively.

Other Liabilities

As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2020, plan assets approximated $2.4 million, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $2.5 million at December 31, 2020 and was included within “Other liabilities” in the Consolidated Balance Sheets. The plan was terminated and fully liquidated during the first quarter of 2021. Other liabilities at September 30, 2021 and December 31, 2020 also included (i) medical and dental benefits for former executives of $1.8 million and $1.9 million, respectively; (ii) asset retirement obligations of $2.8 million and $2.7 million, respectively; and (iii) income tax payables of $1.4 million. Additionally, as a result of the Coronavirus, Aid,

19

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Relief, and Economic Security Act, the Company has accrued for and deferred the deposit and payment of its share of social security taxes, resulting in a liability of $3.5 million at both September 30, 2021 and December 31, 2020, of which $1.7 million is included within “Accrued expenses and other current liabilities”, and $1.8 million is included within “Other liabilities” in the Consolidated Balance Sheets for both periods.

Note 5 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of September 30, 2021 was 13 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at September 30, 2021:

	Operating
	Leases
	(in thousands)
Payments due by period:
2021	$	918
2022		4,679
2023		3,160
2024		2,914
2025		2,508
Thereafter		38,367
Total future minimum lease payments		52,546
Less: Imputed interest		(18,059)
Total	$	34,487
Reported as of September 30, 2021
Accrued expenses and other current liabilities	$	4,162
Long-term operating lease liabilities		30,325
Total	$	34,487

Operating lease cost for the three and nine months ended September 30, 2021 were $1.8 million and $4.8 million, respectively, and $1.3 million and $4.1 million, respectively, for the comparable 2020 periods. Variable lease cost for the three and nine months ended September 30, 2021 were $0.4 million and $1.3 million, respectively, and $0.4 million and $1.3 million, respectively, for the comparable 2020 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the nine months ended September 30, 2021 and 2020 were $4.9 million and $4.8 million, respectively.

Purchase Commitments

Veeco has purchase commitments of $141.6 million at September 30, 2021, substantially all of which become due within one year.

20

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2021, outstanding bank guarantees and standby letters of credit totaled $5.4 million, and unused bank guarantees and letters of credit of $16.7 million were available to be drawn upon.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. The settlement amount will be funded by insurance carriers.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. Plaintiff is appealing the dismissal of its case.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Note 6 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at September 30, 2021 or December 31, 2020. Additionally, the Company did not have any gains or losses from currency exchange derivatives during the nine months ended September 30, 2021 and 2020.

21

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income (loss)	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income (loss)	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income, net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2019	48,994	$	490	$	1,071,058	$	(698,930)	$	1,894	$	374,512
Net income (loss)	—		—		—		(567)		—		(567)
Other comprehensive income (loss), net of tax	—		—		—		—		153		153
Share-based compensation expense	—		—		3,646		—		—		3,646
Net issuance under employee stock plans	434		4		(684)		—		—		(680)
Balance at March 31, 2020	49,428	$	494	$	1,074,020	$	(699,497)	$	2,047	$	377,064
Net income (loss)	—		—		—		(8,302)		—		(8,302)
Other comprehensive income (loss), net of tax	—		—		—		—		(130)		(130)
Share-based compensation expense	—		—		2,974		—		—		2,974
Net issuance under employee stock plans	191		2		753		—		—		755
Extinguishment of equity component of repurchased 2023 Notes	—		—		(80)		—		—		(80)
Equity component of 2027 Notes	—		—		33,363		—		—		33,363
Purchase of capped calls	—		—		(10,313)		—		—		(10,313)
Balance at June 30, 2020	49,619	$	496	$	1,100,717	$	(707,799)	$	1,917	$	395,331
Net income (loss)	—		—		—		580		—		580
Other comprehensive income, net of tax	—		—		—		—		(60)		(60)
Share-based compensation expense	—		—		2,942		—		—		2,942
Net issuance under employee stock plans	(7)		—		(700)		—		—		(700)
Balance at September 30, 2020	49,612	$	496	$	1,102,959	$	(707,219)	$	1,857	$	398,093

22

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2020		1,866		(20)		1,846
Other comprehensive income (loss)		(60)		(16)		(76)
Balance - September 30, 2021	$	1,806	$	(36)	$	1,770

There were minimal reclassifications from AOCI into net income for the three and nine months ended September 30, 2021 and 2020.

Note 8 — Share-based Compensation

Restricted share awards are issued to employees that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to five years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cost of sales	$	620	$	389	$	1,765	$	1,384
Research and development		1,007		674		2,957		2,161
Selling, general, and administrative		2,504		1,879		7,013		6,017
Total	$	4,131	$	2,942	$	11,735	$	9,562

For the nine months ended September 30, 2021, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2020	730		35.26
Expired or forfeited	(285)		40.19
Balance - September 30, 2021	445		32.11

23

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

For the nine months ended September 30, 2021, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2020	2,040		12.73
Granted	879		23.86
Performance award adjustments	(36)		19.75
Vested	(617)		13.84
Forfeited	(64)		14.36
Balance - September 30, 2021	2,202		16.70

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income (loss) before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 2021 and 2020 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Income (loss) before income taxes	$	9,404	$	791	$	18,864	$	(7,760)
Income tax expense (benefit)	$	411	$	211	$	1,029	$	530

The Company’s tax expense for the three months ended September 30, 2021 was $0.4 million, compared to $0.2 million for the comparable prior period. The 2021 tax expense included a $0.4 million expense related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations, compared to 2020 when the expense included a $0.2 million expense related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations.

The Company’s tax expense for the nine months ended September 30, 2021 was $1.0 million, compared to $0.5 million for the comparable prior period. The 2021 tax expense included a $0.2 million expense related to the Company’s domestic operations and a $0.8 million expense related to the Company’s non-U.S. operations, compared to 2020 when the expense included a $0.2 million expense related to the Company’s domestic operations and a $0.3 million expense related to the Company’s non-U.S. operations. The current period domestic tax expense is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The current period foreign tax expense is primarily attributable to non-U.S operation profits and foreign withholding taxes on unremitted earnings as of September 30, 2021, offset by the amortization of intangible assets.

24

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco categorizes its sales into the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography. This market also includes Advanced Packaging which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

25

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Sales by end-market and geographic region for the three and nine months ended September 30, 2021 and 2020 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Sales by end-market
Semiconductor	$	76,320	$	33,578	$	181,641	$	108,461
Compound Semiconductor		23,273		26,584		72,255		62,753
Data Storage		39,256		36,897		132,261		104,085
Scientific & Other		11,397		15,019		44,148		39,917
Total	$	150,246	$	112,078	$	430,305	$	315,216
Sales by geographic region
United States	$	48,776	$	39,602	$	160,908	$	108,869
EMEA(1)		13,564		14,991		36,128		57,271
China		27,261		10,464		68,148		38,328
Rest of APAC		60,589		46,953		164,926		110,328
Rest of World		56		68		195		420
Total	$	150,246	$	112,078	$	430,305	$	315,216

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward Looking Statements

Our discussion below constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made.

Executive Summary

We are an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

COVID-19 Update

As a result of the COVID-19 pandemic, governmental authorities have implemented and are continuing to implement numerous and constantly evolving measures to try to contain the virus, such as travel bans and restrictions, limits on gatherings, quarantines, shelter-in-place orders, vaccine mandates, and business shutdowns. We have important manufacturing operations in the U.S. and Singapore, and sales and support operations in China, Germany, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan and the United Kingdom, all of which have been affected by the COVID-19 pandemic.

Measures providing for business shutdowns generally exclude certain essential services, and those essential services include critical infrastructure and the businesses that support that critical infrastructure. Our operations are considered part of the critical and essential infrastructure defined by applicable government authorities, and, although governmental measures to contain the pandemic may be modified or extended, our manufacturing facilities remain open. We believe our diverse product offerings and the critical nature of certain of our products for infrastructure insulate us, to some extent, from the adverse effects of the pandemic; however, a prolonged economic downturn will adversely affect our customers, which could have a material adverse effect on our revenues, particularly if customers from whom we derive a significant amount of revenue reduce or delay purchases to mitigate the impacts of the pandemic or fail to make payments to us on time or at all.

We serve a global and highly interconnected customer base across the Asia-Pacific region, Europe, and North America. Our net sales to customers located outside of the United States represented approximately 62% of our total net sales for the nine months ended September 30, 2021, and 68% and 70% for the years ended December 31, 2020 and 2019, respectively, and we expect that net sales to customers outside the United States will continue to represent a significant percentage of our total net sales. As a result, our business will be adversely impacted by further deterioration in global economic conditions, particularly in markets in Asia and Europe.

We are starting to see the effects of the macroeconomic inflationary cost environment and supply chain disruptions due to strained transportation capacity, labor shortages and absenteeism associated with COVID-19, and high global demand as markets reopen and economic stimulus drives growth. These effects include longer lead times and increased costs. We are taking proactive steps to manage the impact to our business, including buying in advance and re-sourcing components on a more frequent basis. We continue to monitor our global supply chain and may experience additional disruptions in future periods, which could cause a disruption in our ability to obtain raw materials or components required to manufacture our products.

27

Like many in our industry, we are managing through the effects of the COVID-19 pandemic. Although the full extent of the COVID-19 pandemic’s impact on our business, results of operations, supply chain, and growth can not be predicted or quantified, we proactively identified potential challenges to our business and have been executing business continuity activities to manage disruptions in our business and continue to provide critical infrastructure to our customers. In response to the pandemic, we have taken, or intend to take, the following steps, among others, to keep our employees safe and minimize the spread of the virus, while continuing to serve our customers:

● implemented rigorous health and safety protocols at our manufacturing facilities, including extensively and frequently disinfecting our facilities, limiting access to our facilities, checking temperatures of individuals entering our facilities, staggering shifts to minimize employee overlap in gowning areas, and providing protective equipment;

● mandated remote working arrangements for employees that do not need to be physically present on the manufacturing floor or at customer facilities;

● implemented virtual meetings, customer demos, and factory acceptances to enable customers to review data and performance of their system in our factory remotely via live video;

● performing service and support activities remotely to resolve customer issues and enable our customers to maintain their operations;

● proactively identified gaps in our supply chain and re-sourced a number of components in order to maintain our customer shipment commitments and mitigate single points of failure;

● monitoring our IT systems and implementing contingency and disaster recovery plans to support our IT infrastructure to ensure that our systems remain continuously operative; and

● continuing to monitor and, if necessary, reduce our operating expenses and capital expenditures to maintain financial flexibility and profit margins.

While these steps have been effective so far, there could be additional challenges ahead that may impact either our operations or those of our customers, which could have a negative effect on our financial performance, including productivity and capacity impacts as a result of the ongoing pandemic. We expect to continue to implement these measures until we determine that the COVID-19 pandemic is adequately contained for purposes of our business, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers and suppliers. As a result, we may incur additional expenses in future periods in response to the pandemic, which could adversely affect our financial position, results of operations, or cash flows. In addition, we may revise our approach to these initiatives or take additional actions to meet the needs of our employees and customers, and mitigate the impact of the pandemic on our business.

Business Update

We categorize our revenue by the end-markets into which we sell. Our four end-markets are: Semiconductor; Compound Semiconductor; Data Storage; and Scientific & Other.

Sales in the Semiconductor market were driven by our laser annealing systems for leading and trailing node logic, lithography systems for Advanced Packaging, and our ion beam system for EUV mask blank production. We continue to build momentum for our laser annealing solutions with advanced node logic customers. We are currently production tool of record at multiple leading-edge customers for their most advanced nodes. We also have multiple systems currently being evaluated at both logic and memory customers for their next nodes. Our lithography systems for Advanced Packaging are aligned with longer-term growth of heterogeneous integration, fan-out wafer-level packaging and other Advanced Packaging applications. We are seeing an increase in demand for our lithography systems and recently received a multi-system repeat order from a leading OSAT in support of GPU and high-performance computing device manufacturing. Additionally, EUV Lithography is critical to the progression of Moore’s law, and its ongoing adoption

28

for advanced node, semiconductor manufacturing continues to drive requirements for our mask blank deposition systems. Overall, we believe that our technology and market strategy is well aligned with trends such as artificial intelligence, mobile connectivity and high performance computing that drive the Semiconductor market. We have experienced growth in this market in 2021 and expect the Semiconductor market to contribute toward our 2022 growth. Finally, construction is ahead of schedule at our new San Jose facility, which we believe will allow us to better meet the demands of our semiconductor customers.

We address the Compound Semiconductor market with a broad portfolio of technologies including primarily Wet Processing and MOCVD, along with MBE and Ion Beam, all of which have been developed to support emerging applications such as 5G driven RF device/filter manufacturing, Gallium Nitride power electronics, and photonics applications including edge-emitting lasers and micro-LEDs. Sales in the Compound Semiconductor market were driven by equipment shipments for RF applications, Photonics applications, and power devices.

Sales in the Data Storage market have been growing for several years, primarily driven by shipments of Ion Beam systems. Demand for our Ion Beam products for data storage is being driven by big data and cloud-based storage growth. In order to be successful, hard disk drive manufacturers are required to improve areal density of magnetic heads for hard disk drives and are manufacturing drives with an increasing number of magnetic heads. These two factors taken together have been driving additional capacity requirements and equipment upgrades. However, after multiple years of customers accelerating their capacity additions, including in 2021, we expect revenue to decline from recent levels. With data proliferation forecasted to continue to grow, however, we feel confident about the long-term prospects of our data storage business.

Sales in the Scientific & Other market are largely driven by sales to governments, universities, and research institutions. We are beginning to see signs of a recovery in this market which we expect to grow more in line with GDP.

Overall, while demand for our products remains strong, we continue to monitor and proactively manage actual and potential supply chain challenges related to the inflationary cost environment and supply chain disruptions. Our laser annealing, 5G RF, data storage, and advanced packaging lithography products are all performing well. Long-term revenue growth for 2022 and beyond is expected to primarily come from the Semiconductor market. As such, we have been making strategic investments in R&D and inventory, including evaluation systems, as well as improving our service capabilities, to support anticipated semiconductor growth opportunities. We also continue to make strategic investments in the Compound Semiconductor market in order to capitalize on potential future growth opportunities.

29

Results of Operations

For the three months ended September 30, 2021 and 2020

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the indicated periods in 2021 and 2020 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Three Months Ended September 30,						Change
	2021			2020			Period to Period
	(dollars in thousands)
Net sales	$	150,246	100%	$	112,078	100%	$	38,168	34%
Cost of sales		87,077	58%		62,936	56%		24,141	38%
Gross profit		63,169	42%		49,142	44%		14,027	29%
Operating expenses, net:
Research and development		21,999	15%		19,129	17%		2,870	15%
Selling, general, and administrative		21,603	14%		19,415	17%		2,188	11%
Amortization of intangible assets		2,976	2%		3,831	3%		(855)	(22)%
Other operating expense (income), net		175	-		(218)	-		393	*
Total operating expenses, net		46,753	31%		42,157	38%		4,596	11%
Operating income (loss)		16,416	11%		6,985	6%		9,431	135%
Interest income (expense), net		(7,012)	(5)%		(6,194)	(6)%		(818)	13%
Income (loss) before income taxes		9,404	6%		791	1%		8,613	*
Income tax expense (benefit)		411	-		211	-		200	95%
Net income (loss)	$	8,993	6%	$	580	1%	$	8,413	*

* Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

	Three Months Ended September 30,						Change
	2021			2020			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	76,320	51%	$	33,578	30%	$	42,742	127%
Compound Semiconductor		23,273	15%		26,584	24%		(3,311)	(12)%
Data Storage		39,256	26%		36,897	33%		2,359	6%
Scientific & Other		11,397	8%		15,019	13%		(3,622)	(24)%
Total	$	150,246	100%	$	112,078	100%	$	38,168	34%
Sales by geographic region
United States	$	48,776	33%	$	39,602	36%	$	9,174	23%
EMEA		13,564	9%		14,991	13%		(1,427)	(10)%
China		27,261	18%		10,464	9%		16,797	161%
Rest of APAC		60,589	40%		46,953	42%		13,636	29%
Rest of World		56	-		68	-		(12)	(18)%
Total	$	150,246	100%	$	112,078	100%	$	38,168	34%

Sales increased for the three months ended September 30, 2021 against the comparable prior year period, primarily in the Semiconductor market. By geography, sales increased in the United States, China, and Rest of APAC regions. The increase in sales in the United States was primarily driven by shipments to data storage customers, while the increase in sales in the China and Rest of APAC regions were primarily driven by shipments to semiconductor customers. Sales in the Rest of APAC region for the three months ended September 30, 2021 included sales in Taiwan, South Korea, and

30

Japan of $19.2 million, $14.3 million, and $13.7 million, respectively. Sales in the Rest of APAC region for the three months ended September 30, 2020 included sales in Singapore of $18.0 million. Pricing was not a significant driver of the change in total sales. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the three months ended September 30, 2021, gross profit increased against the comparable prior period primarily due to an increase in sales volume, partially offset by decreased gross margins. Gross margins decreased principally due to product and region mix of sales in the period and an increase in spending to support higher business activity. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the three months ended September 30, 2021 against the comparable prior period primarily due to personnel-related expenses as we selectively invest in new research and development and developing additional applications for our technology in order to be well positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets. However, expenses as a percentage of revenue have decreased when compared to the prior period.

Selling, General, and Administrative

Selling, general, and administrative expenses increased for the three months ended September 30, 2021 against the comparable prior period primarily due to higher variable expenses associated with the increase in revenue, profitability, and order in-take. However, expenses as a percentage of revenue have decreased when compared to the prior year period. Given the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic. In addition, we are currently experiencing duplicate operating expenses for the transition from our existing facility in San Jose, California to our new leased facility, and will continue to do so until this transition is completed over the next several quarters.

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2021.

Interest Income (Expense)

We recorded net interest expense of $7.0 million for the three months ended September 30, 2021, compared to $6.2 million for the comparable prior year period. The increase in interest expense was primarily related to the issuance of the 2027 Notes in May 2020 and the 2025 Notes in November 2020, partially offset by the partial repurchase and exchange of the 2023 Notes. Included in interest expense for the three months ended September 30, 2021 were non-cash charges of $3.7 million related to the amortization of debt discount and transaction costs of the 2023 Notes, 2025 Notes, and 2027 Notes, while the three months ended September 30, 2020 included non-cash charges of $3.5 million related to the amortization of debt discount and transaction costs of the 2023 Notes and 2027 Notes.

31

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the three months ended September 30, 2021 was $0.4 million, compared to $0.2 million for the comparable prior year period. The 2021 tax expense included an expense of $0.4 million related to our non-U.S. operations and minimal expense related to our domestic operations, compared to the comparable period in 2020 when the expense included a $0.2 million expense related to our non-U.S. operations and minimal expense related to our domestic operations.

For the three months ended September 30, 2021 and 2020, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for both periods is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The current period foreign tax expense is primarily attributable to non-U.S operations profits and foreign withholding taxes on unremitted earnings as of September 30, 2021, offset by the amortization of intangible assets.

32

For the nine months ended September 30, 2021 and 2020

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2021 and 2020 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Nine Months Ended September 30,						Change
	2021			2020			Period to Period
	(dollars in thousands)
Net sales	$	430,305	100%	$	315,216	100%	$	115,089	37%
Cost of sales		252,055	59%		177,761	56%		74,294	42%
Gross profit		178,250	41%		137,455	44%		40,795	30%
Operating expenses, net:
Research and development		66,397	15%		57,577	18%		8,820	15%
Selling, general, and administrative		63,325	15%		55,541	18%		7,784	14%
Amortization of intangible assets		9,305	2%		11,502	4%		(2,197)	(19)%
Restructuring		—	-		1,097	0%		(1,097)	*
Asset impairment		—	-		281	-		(281)	*
Other operating expense (income), net		138	-		(502)	-		640	*
Total operating expenses, net		139,165	32%		125,496	40%		13,669	11%
Operating income (loss)		39,085	9%		11,959	4%		27,126	227%
Interest income (expense), net		(20,221)	(5)%		(16,673)	(5)%		(3,548)	21%
Loss on extinguishment of debt		—	-		(3,046)	-		3,046	*
Income (loss) before income taxes		18,864	4%		(7,760)	(2)%		26,624	*
Income tax expense (benefit)		1,029	-		530	-		499	94%
Net income (loss)	$	17,835	4%	$	(8,290)	(3)%	$	26,125	*

* Not meaningful

	Nine Months Ended September 30,						Change
	2021			2020			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	181,641	42%	$	108,461	34%	$	73,180	67%
Compound Semiconductor		72,255	17%		62,753	20%		9,502	15%
Data Storage		132,261	31%		104,085	33%		28,176	27%
Scientific & Other		44,148	10%		39,917	13%		4,231	11%
Total	$	430,305	100%	$	315,216	100%	$	115,089	37%
Sales by geographic region
United States	$	160,908	38%	$	108,869	35%	$	52,039	48%
EMEA		36,128	8%		57,271	18%		(21,143)	(37)%
China		68,148	16%		38,328	12%		29,820	78%
Rest of APAC		164,926	38%		110,328	35%		54,598	49%
Rest of World		195	-		420	-		(225)	(54)%
Total	$	430,305	100%	$	315,216	100%	$	115,089	37%

Sales increased for the nine months ended September 30, 2021 against the comparable prior year period across all markets. By geography, sales increased in the United States, China, and Rest of APAC regions, partially offset by a decrease in a sales in the EMEA region. The increase in sales in the United States was primarily driven by shipments to data storage customers, while the increase in sales in the Rest of APAC region was primarily driven by shipments to semiconductor and data storage customers. The increase in sales in the China region was primarily driven by shipments to semiconductor customers. The decrease in sales in the EMEA region was primarily driven by a decrease in shipments to data storage customers. Sales in the Rest of APAC region for the nine months ended September 30, 2021 included

33

sales in Taiwan and South Korea of $53.0 million and $39.9 million, respectively. Sales in the Rest of APAC region for the nine months ended September 30, 2020 included sales in Singapore and Taiwan of $34.0 million and $29.2 million, respectively. Pricing was not a significant driver of the change in total sales. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the nine months ended September 30, 2021, gross profit increased against the comparable prior year period primarily due to an increase in sales volume, partially offset by decreased gross margins. Gross margins decreased principally due to an increase in spending to support higher business activity, as well as product and region mix of sales in the period. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the nine months ended September 30, 2021 against the comparable prior year period primarily due to personnel-related expenses as we selectively invest in new research and development and developing additional applications for our technology in order to be well positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets. However, expenses as a percentage of revenue have decreased when compared to the comparable prior year period.

Selling, General, and Administrative

Selling, general, and administrative expenses increased for the nine months ended September 30, 2021 against the comparable prior year period primarily due to higher variable expenses associated with the increase in revenue, profitability, and order in-take. However, expenses as a percentage of revenue have decreased when compared to the prior year period. Given the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic. In addition, we are currently experiencing duplicate operating expenses for the transition from our existing facility in San Jose, California to our new leased facility, and will continue to do so until this transition is completed over the next several quarters.

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2021.

Interest Income (Expense)

We recorded net interest expense of $20.2 million for the nine months ended September 30, 2021, compared to $16.7 million for the comparable prior year period. The increase in interest expense was primarily related to the issuance of the 2027 Notes in May 2020 and the 2025 Notes in November 2020, partially offset by the partial repurchase and exchange of the 2023 Notes. Included in interest expense for the nine months ended September 30, 2021 were non-cash charges of $10.8 million related to the amortization of debt discount and transaction costs of the 2023 Notes, 2025 Notes, and 2027 Notes, while the nine months ended September 30, 2020 included non-cash charges of $10.3 million related to the amortization of debt discount and transaction costs of the 2023 Notes and 2027 Notes. Additionally, interest income decreased approximately $1.0 million for the nine months ended September 30, 2021 compared to the prior year period, primarily as a result of lower interest rates, and we expect interest income to remain depressed as a result.

34

Loss on Extinguishment of Debt

On May 18, 2020, in connection with the completion of a private offering of $125 million aggregate principal amount of 3.75% convertible senior notes, we repurchased and retired approximately $88.3 million in aggregate principal amount of our outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash. We accounted for the repurchase of the $88.3 million of the 2023 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $3.0 million for the nine months ended September 30, 2020.

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the nine months ended September 30, 2021 was $1.0 million, compared to $0.5 million for the comparable prior year period. The 2021 tax expense included an expense of $0.2 million related to our domestic operations and $0.8 million related to our non-U.S. operations, compared to 2020 when the expense included a $0.2 million expense related to our domestic operations and a $0.3 million expense related to our non-U.S. operations.

For the nine months ended September 30, 2021 and 2020, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for the current period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The current period foreign tax expense is primarily attributable to non-U.S operation profits and foreign withholding taxes on unremitted earnings as of September 30, 2021, offset by the amortization of intangible assets.

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

	September 30,		December 31,
	2021		2020
	(in thousands)
Cash and cash equivalents	$	121,602	$	129,625
Restricted cash		629		658
Short-term investments		213,985		189,771
Total	$	336,216	$	320,054

At September 30, 2021 and December 31, 2020, cash and cash equivalents of $45.0 million and $40.2 million, respectively, were held outside the United States. As of September 30, 2021, we had $16.8 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided and did not require the use of cash due to the use of net operating loss carryforwards. Approximately $7.1 million of undistributed earnings will be subject to foreign withholding taxes if distributed back to the United States.

We believe that our projected cash flow from operations, combined with our cash and short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our convertible senior notes, purchase commitments, and payments in respect of operating leases. Although there is uncertainty related to the anticipated impact of the COVID-19 outbreak on our future results, we believe our business model, our current cash and short-term investments, and our proactive management of expenses, leave us well-positioned to manage our business through this crisis as it continues to unfold.

35

A summary of the cash flow activity for the nine months ended September 30, 2021 and 2020 is as follows:

Cash Flows from Operating Activities

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Net income (loss)	$	17,835	$	(8,290)
Non-cash items:
Depreciation and amortization		19,634		23,021
Non-cash interest expense		10,762		10,282
Deferred income taxes		(12)		330
Share-based compensation expense		11,735		9,562
Loss on extinguishment of debt		—		3,046
Asset impairment		—		281
Provision for bad debts		—		140
Changes in operating assets and liabilities		(9,305)		(10,781)
Net cash provided by (used in) operating activities	$	50,649	$	27,591

Net cash provided by operating activities was $50.6 million for the nine months ended September 30, 2021 and was due to net income of $17.8 million and adjustments for non-cash items of $42.1 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $9.3 million. The changes in operating assets and liabilities were largely attributable to increases in accounts receivable and inventories, partially offset by increases in accounts payable and accrued expenses.

Cash Flows from Investing Activities

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Capital expenditures	$	(31,453)	$	(3,331)
Changes in investments, net		(25,637)		(46,045)
Proceeds from held for sale assets, net of costs to sell		—		9,503
Net cash provided by (used in) investing activities	$	(57,090)	$	(39,873)

The cash used by investing activities during the nine months ended September 30, 2021 was primarily attributable capital expenditures, as well as net changes in investments. We expect increased capital expenditures associated with the build-out of our newly leased facility in San Jose, California over the next several quarters. In addition, we expect a period of duplicate operating expenses until the transition from our existing facility to our new facility is completed. The cash used in investing activities during the nine months ended September 30, 2020 was primarily attributable to the net changes in investments, as well as capital expenditures, partially offset by the net proceeds from the sale of a non-core product line.

Cash Flows from Financing Activities

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Proceeds from issuance of 2027 Notes, net of issuance costs	$	—	$	121,946
Purchase of capped calls		—		(10,313)
Repurchase of 2023 Notes		—		(81,240)
Settlement of equity awards, net of withholding taxes		(1,551)		211
Net cash provided by (used in) financing activities	$	(1,551)	$	30,604

36

The cash used in financing activities for the nine months ended September 30, 2021 was related to cash used to settle taxes related to employee equity programs, partially offset by cash received under the Employee Stock Purchase Plan. The cash provided by financing activities for the nine months ended September 30, 2020 was primarily related to the net cash proceeds received from the issuance of the 2027 Notes, partially offset by the cash used to repurchase $88.3 million principal amount of our outstanding 2023 Notes as well as the purchase of the capped call transactions.

Convertible Senior Notes

We have $131.7 million outstanding principal balance of 2.70% convertible senior notes that bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. In addition, we have $132.5 million outstanding principal balance of 3.50% convertible senior notes that bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted. Finally, we have $125.0 million outstanding principal balance of 3.75% convertible senior notes that bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted. The 2027 Notes are currently convertible by shareholders until December 31, 2021.

We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on these debts, as well as the payment in cash of principal amounts of any notes that are converted.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, and results of operations, liquidity, capital expenditures or capital resources other than bank guarantees and purchase commitments disclosed in the preceding footnotes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $214.0 million at September 30, 2021. These securities are subject to interest rate risk and, based on our investment portfolio at September 30, 2021, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $2.1 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating

37

strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

Changes in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. We only use derivative financial instruments in the context of hedging and not for speculative purposes and have not historically designated our foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other, net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 67% and 62% of our total net sales for the three and nine months ended September 30, 2021, respectively, and 64% and 65% for the comparable 2020 periods. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies other than the U.S. dollar represented 3% of total net sales in both the three and nine months ended September 30, 2021, and 7% and 5% for the comparable 2020 periods.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of September 30, 2021. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

During the quarter ended September 30, 2021, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. The settlement amount will be funded by insurance carriers.

38

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. Plaintiff is appealing the dismissal of its case.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 1A. Risk Factors

Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q and in Part I — Item 1A of our 2020 Form 10-K. There have been no material changes from the risk factors previously disclosed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

39

Item 6. Exhibits

Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.

Exhibit		Incorporated by Reference			Filed or Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
31.1	Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.				*
101.XSD	XBRL Schema.				**
101.PRE	XBRL Presentation.				**
101.CAL	XBRL Calculation.				**
101.DEF	XBRL Definition.				**
101.LAB	XBRL Label.				**
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).				**

*     Filed herewith

**   Filed herewith electronically

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 2, 2021.

Veeco Instruments Inc.
By:	/S/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer

41

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I, William J. Miller, Ph.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2021 of Veeco Instruments Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	November 2, 2021

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I,  John P. Kiernan, certify that:

1.    I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2021 of Veeco Instruments Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	November 2, 2021

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William J. Miller, Ph.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ WILLIAM J. MILLER Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	November 2, 2021

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Kiernan, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	November 2, 2021

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Oct. 27, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	0-16244
Entity Registrant Name	VEECO INSTRUMENTS INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2989601
Entity Address, Address Line One	Terminal Drive
Entity Address, City or Town	Plainview
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11803
City Area Code	516
Local Phone Number	677-0200
Title of 12(b) Security	Common Stock
Trading Symbol	VECO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,503,953
Entity Central Index Key	0000103145
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 121,602	$ 129,625
Restricted cash	629	658
Short-term investments	213,985	189,771
Accounts receivable, net	86,759	79,991
Contract assets	27,467	21,246
Inventories	170,835	145,906
Deferred cost of sales	635	433
Prepaid expenses and other current assets	31,592	19,301
Total current assets	653,504	586,931
Property, plant, and equipment, net	93,851	65,271
Operating lease right-of-use assets	26,481	10,275
Intangible assets, net	36,880	46,185
Goodwill	181,943	181,943
Deferred income taxes	1,440	1,440
Other assets	3,709	6,019
Total assets	997,808	898,064
Current liabilities:
Accounts payable	48,749	33,656
Accrued expenses and other current liabilities	76,033	44,876
Customer deposits and deferred revenue	60,703	67,235
Income taxes payable	1,737	914
Total current liabilities	187,222	146,681
Deferred income taxes	5,228	5,240
Long-term debt	331,877	321,115
Long-term operating lease liabilities	30,325	6,305
Other liabilities	7,843	10,349
Total liabilities	562,495	489,690
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.
Common stock, $0.01 par value; 120,000,000 shares authorized; 50,321,048 shares issued and outstanding at September 30, 2021 and 49,723,751 shares issued and outstanding at December 31, 2020	503	497
Additional paid-in capital	1,122,526	1,113,352
Accumulated deficit	(689,486)	(707,321)
Accumulated other comprehensive income	1,770	1,846
Total stockholders' equity	435,313	408,374
Total liabilities and stockholders' equity	$ 997,808	$ 898,064

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Consolidated Balance Sheets
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized shares	120,000,000	120,000,000
Common stock, shares issued	50,321,048	49,723,751
Common stock, shares outstanding	50,321,048	49,723,751

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Consolidated Statements of Operations
Net sales	$ 150,246	$ 112,078	$ 430,305	$ 315,216
Cost of sales	87,077	62,936	252,055	177,761
Gross profit	63,169	49,142	178,250	137,455
Operating expenses, net:
Research and development	21,999	19,129	66,397	57,577
Selling, general, and administrative	21,603	19,415	63,325	55,541
Amortization of intangible assets	2,976	3,831	9,305	11,502
Restructuring				1,097
Asset impairment				281
Other operating expense (income), net	175	(218)	138	(502)
Total operating expenses, net	46,753	42,157	139,165	125,496
Operating income (loss)	16,416	6,985	39,085	11,959
Interest income	95	231	464	1,458
Interest expense	(7,107)	(6,425)	(20,685)	(18,131)
Loss on extinguishment of debt				(3,046)
Income (loss) before income taxes	9,404	791	18,864	(7,760)
Income tax expense (benefit)	411	211	1,029	530
Net income (loss)	$ 8,993	$ 580	$ 17,835	$ (8,290)
Income (loss) per common share:
Basic (in dollars per share)	$ 0.18	$ 0.01	$ 0.36	$ (0.17)
Diluted (in dollars per share)	$ 0.17	$ 0.01	$ 0.33	$ (0.17)
Weighted average number of shares:
Basic (in shares)	49,021	48,341	48,968	48,327
Diluted (in shares)	53,849	49,174	53,606	48,327

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Consolidated Statements of Comprehensive Income (Loss)
Net income (loss)	$ 8,993	$ 580	$ 17,835	$ (8,290)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities	(12)	(69)	(16)	(16)
Change in currency translation adjustments	(21)	9	(60)	(21)
Total other comprehensive income (loss), net of tax	(33)	(60)	(76)	(37)
Total comprehensive income (loss)	$ 8,960	$ 520	$ 17,759	$ (8,327)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities
Net income (loss)	$ 17,835	$ (8,290)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	19,634	23,021
Non-cash interest expense	10,762	10,282
Deferred income taxes	(12)	330
Share-based compensation expense	11,735	9,562
Loss on extinguishment of debt		3,046
Asset impairment		281
Provision for bad debts		140
Changes in operating assets and liabilities:
Accounts receivable and contract assets	(12,987)	(30,677)
Inventories and deferred cost of sales	(24,879)	(10,336)
Prepaid expenses and other current assets	9,829	(982)
Accounts payable and accrued expenses	21,786	11,130
Customer deposits and deferred revenue	(6,532)	16,728
Income taxes receivable and payable, net	823	61
Other, net	2,655	3,295
Net cash provided by (used in) operating activities	50,649	27,591
Cash Flows from Investing Activities
Capital expenditures	(31,453)	(3,331)
Proceeds from the sale of investments	199,475	139,531
Payments for purchases of investments	(225,112)	(185,576)
Proceeds from held for sale assets, net of costs to sell		9,503
Net cash provided by (used in) investing activities	(57,090)	(39,873)
Cash Flows from Financing Activities
Proceeds from issuance of 2027 Notes, net of issuance costs		121,946
Purchase of capped calls		(10,313)
Repurchase of 2023 Notes		(81,240)
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan	2,709	2,428
Restricted stock tax withholdings	(4,260)	(2,217)
Net cash provided by (used in) financing activities	(1,551)	30,604
Effect of exchange rate changes on cash and cash equivalents	(60)	(21)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(8,052)	18,301
Cash, cash equivalents, and restricted cash - beginning of period	130,283	129,951
Cash, cash equivalents, and restricted cash - end of period	122,231	148,252
Supplemental Disclosure of Cash Flow Information
Interest paid	9,039	8,989
Net income taxes paid (refunds received)	(130)	248
Non-cash operating and financing activities
Capital expenditures included in accounts payable and accrued expenses	9,133	705
Net transfer of property, plant and equipment to inventory	253	1,624
Right-of-use assets obtained in exchange for lease obligations	$ 20,353	$ 951

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2021

Basis of Presentation

Basis of Presentation

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2021 interim quarters end on April 4, July 4, and October 3, and the 2020 interim quarters ended on March 29, June 28, and September 27. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

The Company adopted ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes in the second quarter of 2020, effective as of the beginning of fiscal year 2020. This ASU simplifies the accounting for income taxes by eliminating certain exceptions to the general principles and simplifying several aspects of ASC 740, Income Taxes, including, but not limited to, requirements related to the following: a) exception to the incremental approach for intraperiod tax allocation; b) the tax basis step-up in goodwill obtained in a transaction that is not a business combination; c) ownership changes in investments - changes from a subsidiary to an equity method investment; d) separate financial statements of entities not subject to tax; e) interim-period accounting for enacted changes in tax law; and f) the year-to-date loss limitation in interim-period tax accounting. The adoption did not have a material impact on the Company’s consolidated financial statements as of the date of adoption.

Recent Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021. The Company’s 2023 Notes, 2025 Notes, and 2027 Notes all are currently accounted for using the separation models for convertible debt with a cash conversion feature, and therefore upon adoption of ASU 2020-06 in the first quarter of 2022, the Company expects a decrease in non-cash interest expense. Additionally, the Company will be required to use the if-converted method for its current convertible debt when calculating diluted earnings (loss) per share, which will result in an increase in income available to common shareholders, as well as an increase in diluted shares outstanding. The Company expects to use the modified retrospective method of adoption.

i

XML

Income (Loss) Per Common Share

9 Months Ended

Sep. 30, 2021

Income (Loss) Per Common Share

Income (Loss) Per Common Share

Note 2 — Income (Loss) Per Common Share

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income (loss) per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. The Company has determined that it has the ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock. As such, the Company accounts for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive. The computations of basic and diluted income (loss) per share for the three and nine months ended September 30, 2021 and 2020 are as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands, except per share amounts)
Net income (loss)	$	8,993	$	580	$	17,835	$	(8,290)
Net income (loss) per common share:
Basic	$	0.18	$	0.01	$	0.36	$	(0.17)
Diluted	$	0.17	$	0.01	$	0.33	$	(0.17)
Basic weighted average shares outstanding		49,021		48,341		48,968		48,327
Dilutive effect of share-based awards		1,507		833		1,377
Dilutive effect of the 2027 Notes		3,321		—		3,261		—
Diluted weighted average shares outstanding		53,849		49,174		53,606		48,327
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		N/A		N/A		N/A		650
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		451		984		447		1,029
Maximum potential shares to be issued for settlement of the 2023, 2025, and 2027 Notes excluded from the diluted calculation as their effect would be antidilutive due to a net loss or the fact that the conversion value of the Notes did not exceed their principal amount		8,811		15,354		8,811		15,354

XML

Assets

9 Months Ended

Sep. 30, 2021

Assets

Assets

Note 3 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2021
Cash equivalents
Certificate of deposits and time deposits	$	55,358	$	—	$	—	$	55,358
Corporate debt		—		—		—		—
Commercial paper		—		—		—		—
Money market cash		1,069		—		—		1,069
Total	$	56,427	$	—	$	—	$	56,427
Short-term investments
U.S. treasuries	$	118,782	$	—	$	—	$	118,782
Government agency securities		—		12,086		—		12,086
Corporate debt		—		67,678		—		67,678
Commercial paper		—		15,439		—		15,439
Total	$	118,782	$	95,203	$	—	$	213,985
December 31, 2020
Cash equivalents
Certificate of deposits and time deposits	$	59,168	$	—	$	—	$	59,168
Commercial paper		—		2,000		—		2,000
U.S. treasuries		24,997		—		—		24,997
Total	$	84,165	$	2,000	$	—	$	86,165
Short-term investments
U.S. treasuries	$	149,219	$	—	$	—	$	149,219
Corporate debt		—		32,554		—		32,554
Commercial paper		—		7,998		—		7,998
Total	$	149,219	$	40,552	$	—	$	189,771

There were no transfers between fair value measurement levels during the three and nine months ended September 30, 2021.

At September 30, 2021 and December 31, 2020, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2021
U.S. treasuries	$	118,801	$	9	$	(28)	$	118,782
Government agency securities		12,092		—		(6)		12,086
Corporate debt		67,689		28		(39)		67,678
Commercial paper		15,439		—		—		15,439
Total	$	214,021	$	37	$	(73)	$	213,985
December 31, 2020
U.S. treasuries	$	149,206	$	14	$	(1)	$	149,219
Corporate debt		32,588		—		(34)		32,554
Commercial paper		7,997		1		—		7,998
Total	$	189,791	$	15	$	(35)	$	189,771

Available-for-sale securities in a loss position at September 30, 2021 and December 31, 2020 consist of:

	September 30, 2021				December 31, 2020
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	64,093	$	(28)	$	19,991	$	(1)
Government agency securities		12,086		(6)		—		—
Corporate debt		39,549		(39)		32,554		(34)
Total	$	115,728	$	(73)	$	52,545	$	(35)

At September 30, 2021 and December 31, 2020, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The contractual maturities of securities classified as available-for-sale at September 30, 2021 were as follows:

	September 30, 2021
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	121,123	$	121,128
Due after one year through two years		87,080		87,037
Due after two years through three years		5,818		5,820
Total	$	214,021	$	213,985

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were minimal realized gains or losses for the nine months ended September 30, 2021 and no realized gains or losses for the nine months ended September 30, 2020.

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $0.7 million at September 30, 2021 and December 31, 2020. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts.

Inventories

Inventories at September 30, 2021 and December 31, 2020 consist of the following:

	September 30,		December 31,
	2021		2020
	(in thousands)
Materials	$	90,982	$	82,679
Work-in-process		64,134		53,979
Finished goods		15,719		9,248
Total	$	170,835	$	145,906

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. The balance as of September 30, 2021 includes a current receivable of $15.0 million for insurance recoveries related to the legal settlement referenced in Note 5, “Commitments and Contingencies,” as well as a current receivable of $1.1 million related to landlord reimbursement for leasehold improvements associated with the Company’s new leased facility in San Jose, California. In addition, Veeco had deposits with its suppliers of $4.2 million and $7.2 million at September 30, 2021 and December 31, 2020, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at September 30, 2021 and December 31, 2020 consist of the following:

	September 30,		December 31,
	2021		2020
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		63,944		62,865
Machinery and equipment (1)		144,937		140,493
Leasehold improvements		38,262		6,671
Gross property, plant, and equipment		252,204		215,090
Less: accumulated depreciation and amortization		158,353		149,819
Net property, plant, and equipment	$	93,851	$	65,271

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and nine months ended September 30, 2021, depreciation expense was $3.5 million and $10.3 million, respectively, and $3.8 million and $11.5 million, respectively, for the comparable 2020 periods.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The Company continues to assess potential triggering events related to

the value of its goodwill and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2021.

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2021.

The components of purchased intangible assets were as follows:

	September 30, 2021						December 31, 2020
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	308,587	$	19,321	$	327,908	$	302,358	$	25,550
Customer relationships		146,465		132,260		14,205		146,465		130,131		16,334
Trademarks and tradenames		30,910		27,556		3,354		30,910		26,614		4,296
Other		3,686		3,686		—		3,686		3,681		5
Total	$	508,969	$	472,089	$	36,880	$	508,969	$	462,784	$	46,185

Other intangible assets primarily consist of patents, licenses, and backlog.

XML

Liabilities

9 Months Ended

Sep. 30, 2021

Liabilities

Liabilities

Note 4 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at September 30, 2021 and December 31, 2020 consist of:

	September 30,		December 31,
	2021		2020
	(in thousands)
Payroll and related benefits	$	33,868	$	26,630
Warranty		6,544		5,058
Operating lease liabilities		4,162		4,148
Interest		3,459		2,574
Professional fees		1,140		1,112
Legal settlement		15,000		—
Sales, use, and other taxes		6,092		2,658
Other		5,768		2,696
Total	$	76,033	$	44,876

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the nine months ended September 30, 2021 include:

		(in thousands)
Balance - December 31, 2020	$	5,058
Warranties issued		4,766
Consumption of reserves		(4,401)
Changes in estimate		1,121
Balance - September 30, 2021	$	6,544

Customer Deposits and Deferred Revenue

Customer deposits totaled $44.6 million and $49.3 million at September 30, 2021 and December 31, 2020, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2020	$	17,985
Deferral of revenue		7,008
Recognition of unearned revenue		(8,913)
Balance - September 30, 2021	$	16,080

As of September 30, 2021, the Company has approximately $34.6 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 73% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately

$88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

The 2023 Notes, 2025 Notes, and 2027 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 24.9800, 41.6667, and 71.5372 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, representing initial effective conversion prices of $40.03, $24.00, and $13.98 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for

each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended September 30, 2021, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until December 31, 2021.

Holders may convert their notes at any time, regardless of the foregoing circumstances, on or after October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, until the close of business on the business day immediately preceding the respective maturity date.

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion options, the Company segregated the liability component of the instruments from the equity components. The liability components were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Notes. The calculation of the fair value of the debt components required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Notes at a discount rate equal to the estimated borrowing rate for similar non-convertible debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face values of the Notes over the estimated fair values of the liability components of $72.5 million, $21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as debt discounts and recorded as an increase to additional paid-in capital and will be amortized over the expected lives of the Notes using the effective interest rate method. Amortization of the debt discounts are recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected terms of the Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity components recognized in stockholders' equity.

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call

Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

The carrying value of the 2023 Notes, 2025 Notes and 2027 Notes are as follows:

		September 30, 2021						December 31, 2020
		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	131,695	$	(7,754)	$	123,941	$	131,695	$	(11,925)	$	119,770
2025 Notes		132,500		(18,539)		113,961		132,500		(22,097)		110,403
2027 Notes		125,000		(31,025)		93,975		125,000		(34,058)		90,942
Net carrying value	$	389,195	$	(57,318)	$	331,877	$	389,195	$	(68,080)	$	321,115

Total interest expense related to the 2023 Notes, 2025 Notes and 2027 Notes is as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	889	$	1,733	$	2,667	$	6,060
Coupon interest expense - 2025 Notes		1,159		—		3,478		—
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		1,745
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		1,417		2,563		4,171		8,887
Amortization of debt discount/transaction costs- 2025 Notes		1,211		—		3,558		—
Amortization of debt discount/transaction costs- 2027 Notes		1,035		941		3,033		1,395
Total Interest Expense	$	6,883	$	6,409	$	20,423	$	18,087

The Company determined the 2023 Notes, 2025 notes, and 2027 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at September 30, 2021 of $132.6 million, $158.2, and $223.9 million, respectively.

Other Liabilities

As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2020, plan assets approximated $2.4 million, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $2.5 million at December 31, 2020 and was included within “Other liabilities” in the Consolidated Balance Sheets. The plan was terminated and fully liquidated during the first quarter of 2021. Other liabilities at September 30, 2021 and December 31, 2020 also included (i) medical and dental benefits for former executives of $1.8 million and $1.9 million, respectively; (ii) asset retirement obligations of $2.8 million and $2.7 million, respectively; and (iii) income tax payables of $1.4 million. Additionally, as a result of the Coronavirus, Aid,

Relief, and Economic Security Act, the Company has accrued for and deferred the deposit and payment of its share of social security taxes, resulting in a liability of $3.5 million at both September 30, 2021 and December 31, 2020, of which $1.7 million is included within “Accrued expenses and other current liabilities”, and $1.8 million is included within “Other liabilities” in the Consolidated Balance Sheets for both periods.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Commitments and Contingencies

Note 5 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of September 30, 2021 was 13 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at September 30, 2021:

	Operating
	Leases
	(in thousands)
Payments due by period:
2021	$	918
2022		4,679
2023		3,160
2024		2,914
2025		2,508
Thereafter		38,367
Total future minimum lease payments		52,546
Less: Imputed interest		(18,059)
Total	$	34,487
Reported as of September 30, 2021
Accrued expenses and other current liabilities	$	4,162
Long-term operating lease liabilities		30,325
Total	$	34,487

Operating lease cost for the three and nine months ended September 30, 2021 were $1.8 million and $4.8 million, respectively, and $1.3 million and $4.1 million, respectively, for the comparable 2020 periods. Variable lease cost for the three and nine months ended September 30, 2021 were $0.4 million and $1.3 million, respectively, and $0.4 million and $1.3 million, respectively, for the comparable 2020 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the nine months ended September 30, 2021 and 2020 were $4.9 million and $4.8 million, respectively.

Purchase Commitments

Veeco has purchase commitments of $141.6 million at September 30, 2021, substantially all of which become due within one year.

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2021, outstanding bank guarantees and standby letters of credit totaled $5.4 million, and unused bank guarantees and letters of credit of $16.7 million were available to be drawn upon.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. The settlement amount will be funded by insurance carriers.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. Plaintiff is appealing the dismissal of its case.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2021

Derivative Financial Instruments

Derivative Financial Instruments

Note 6 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at September 30, 2021 or December 31, 2020. Additionally, the Company did not have any gains or losses from currency exchange derivatives during the nine months ended September 30, 2021 and 2020.

XML

Equity

9 Months Ended

Sep. 30, 2021

Stockholders' Equity

Equity

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income (loss)	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income (loss)	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income, net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2019	48,994	$	490	$	1,071,058	$	(698,930)	$	1,894	$	374,512
Net income (loss)	—		—		—		(567)		—		(567)
Other comprehensive income (loss), net of tax	—		—		—		—		153		153
Share-based compensation expense	—		—		3,646		—		—		3,646
Net issuance under employee stock plans	434		4		(684)		—		—		(680)
Balance at March 31, 2020	49,428	$	494	$	1,074,020	$	(699,497)	$	2,047	$	377,064
Net income (loss)	—		—		—		(8,302)		—		(8,302)
Other comprehensive income (loss), net of tax	—		—		—		—		(130)		(130)
Share-based compensation expense	—		—		2,974		—		—		2,974
Net issuance under employee stock plans	191		2		753		—		—		755
Extinguishment of equity component of repurchased 2023 Notes	—		—		(80)		—		—		(80)
Equity component of 2027 Notes	—		—		33,363		—		—		33,363
Purchase of capped calls	—		—		(10,313)		—		—		(10,313)
Balance at June 30, 2020	49,619	$	496	$	1,100,717	$	(707,799)	$	1,917	$	395,331
Net income (loss)	—		—		—		580		—		580
Other comprehensive income, net of tax	—		—		—		—		(60)		(60)
Share-based compensation expense	—		—		2,942		—		—		2,942
Net issuance under employee stock plans	(7)		—		(700)		—		—		(700)
Balance at September 30, 2020	49,612	$	496	$	1,102,959	$	(707,219)	$	1,857	$	398,093

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2020		1,866		(20)		1,846
Other comprehensive income (loss)		(60)		(16)		(76)
Balance - September 30, 2021	$	1,806	$	(36)	$	1,770

There were minimal reclassifications from AOCI into net income for the three and nine months ended September 30, 2021 and 2020.

XML

Share-based Compensation

9 Months Ended

Sep. 30, 2021

Share-based Compensation

Stock Plans

Note 8 — Share-based Compensation

Restricted share awards are issued to employees that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to five years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cost of sales	$	620	$	389	$	1,765	$	1,384
Research and development		1,007		674		2,957		2,161
Selling, general, and administrative		2,504		1,879		7,013		6,017
Total	$	4,131	$	2,942	$	11,735	$	9,562

For the nine months ended September 30, 2021, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2020	730		35.26
Expired or forfeited	(285)		40.19
Balance - September 30, 2021	445		32.11

For the nine months ended September 30, 2021, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2020	2,040		12.73
Granted	879		23.86
Performance award adjustments	(36)		19.75
Vested	(617)		13.84
Forfeited	(64)		14.36
Balance - September 30, 2021	2,202		16.70

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Taxes

Income Taxes

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income (loss) before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 2021 and 2020 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Income (loss) before income taxes	$	9,404	$	791	$	18,864	$	(7,760)
Income tax expense (benefit)	$	411	$	211	$	1,029	$	530

The Company’s tax expense for the three months ended September 30, 2021 was $0.4 million, compared to $0.2 million for the comparable prior period. The 2021 tax expense included a $0.4 million expense related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations, compared to 2020 when the expense included a $0.2 million expense related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations.

The Company’s tax expense for the nine months ended September 30, 2021 was $1.0 million, compared to $0.5 million for the comparable prior period. The 2021 tax expense included a $0.2 million expense related to the Company’s domestic operations and a $0.8 million expense related to the Company’s non-U.S. operations, compared to 2020 when the expense included a $0.2 million expense related to the Company’s domestic operations and a $0.3 million expense related to the Company’s non-U.S. operations. The current period domestic tax expense is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The current period foreign tax expense is primarily attributable to non-U.S operation profits and foreign withholding taxes on unremitted earnings as of September 30, 2021, offset by the amortization of intangible assets.

XML

Segment Reporting and Geographic Information

9 Months Ended

Sep. 30, 2021

Segment Reporting and Geographic Information

Segment Reporting and Geographic Information

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco categorizes its sales into the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography. This market also includes Advanced Packaging which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

Sales by end-market and geographic region for the three and nine months ended September 30, 2021 and 2020 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Sales by end-market
Semiconductor	$	76,320	$	33,578	$	181,641	$	108,461
Compound Semiconductor		23,273		26,584		72,255		62,753
Data Storage		39,256		36,897		132,261		104,085
Scientific & Other		11,397		15,019		44,148		39,917
Total	$	150,246	$	112,078	$	430,305	$	315,216
Sales by geographic region
United States	$	48,776	$	39,602	$	160,908	$	108,869
EMEA(1)		13,564		14,991		36,128		57,271
China		27,261		10,464		68,148		38,328
Rest of APAC		60,589		46,953		164,926		110,328
Rest of World		56		68		195		420
Total	$	150,246	$	112,078	$	430,305	$	315,216

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2021

Basis of Presentation

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Fiscal Period

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2021 interim quarters end on April 4, July 4, and October 3, and the 2020 interim quarters ended on March 29, June 28, and September 27. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

The Company adopted ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes in the second quarter of 2020, effective as of the beginning of fiscal year 2020. This ASU simplifies the accounting for income taxes by eliminating certain exceptions to the general principles and simplifying several aspects of ASC 740, Income Taxes, including, but not limited to, requirements related to the following: a) exception to the incremental approach for intraperiod tax allocation; b) the tax basis step-up in goodwill obtained in a transaction that is not a business combination; c) ownership changes in investments - changes from a subsidiary to an equity method investment; d) separate financial statements of entities not subject to tax; e) interim-period accounting for enacted changes in tax law; and f) the year-to-date loss limitation in interim-period tax accounting. The adoption did not have a material impact on the Company’s consolidated financial statements as of the date of adoption.

Recent Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021. The Company’s 2023 Notes, 2025 Notes, and 2027 Notes all are currently accounted for using the separation models for convertible debt with a cash conversion feature, and therefore upon adoption of ASU 2020-06 in the first quarter of 2022, the Company expects a decrease in non-cash interest expense. Additionally, the Company will be required to use the if-converted method for its current convertible debt when calculating diluted earnings (loss) per share, which will result in an increase in income available to common shareholders, as well as an increase in diluted shares outstanding. The Company expects to use the modified retrospective method of adoption.

XML

Income (Loss) Per Common Share (Tables)

9 Months Ended

Sep. 30, 2021

Income (Loss) Per Common Share

Schedule of basic and diluted income (loss) per share and weighted average shares

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands, except per share amounts)
Net income (loss)	$	8,993	$	580	$	17,835	$	(8,290)
Net income (loss) per common share:
Basic	$	0.18	$	0.01	$	0.36	$	(0.17)
Diluted	$	0.17	$	0.01	$	0.33	$	(0.17)
Basic weighted average shares outstanding		49,021		48,341		48,968		48,327
Dilutive effect of share-based awards		1,507		833		1,377
Dilutive effect of the 2027 Notes		3,321		—		3,261		—
Diluted weighted average shares outstanding		53,849		49,174		53,606		48,327
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		N/A		N/A		N/A		650
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		451		984		447		1,029
Maximum potential shares to be issued for settlement of the 2023, 2025, and 2027 Notes excluded from the diluted calculation as their effect would be antidilutive due to a net loss or the fact that the conversion value of the Notes did not exceed their principal amount		8,811		15,354		8,811		15,354

XML

Assets (Tables)

9 Months Ended

Sep. 30, 2021

Assets

Schedule of portion of Veeco's assets (excluding cash balances) that are measured at fair value on a recurring basis

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2021
Cash equivalents
Certificate of deposits and time deposits	$	55,358	$	—	$	—	$	55,358
Corporate debt		—		—		—		—
Commercial paper		—		—		—		—
Money market cash		1,069		—		—		1,069
Total	$	56,427	$	—	$	—	$	56,427
Short-term investments
U.S. treasuries	$	118,782	$	—	$	—	$	118,782
Government agency securities		—		12,086		—		12,086
Corporate debt		—		67,678		—		67,678
Commercial paper		—		15,439		—		15,439
Total	$	118,782	$	95,203	$	—	$	213,985
December 31, 2020
Cash equivalents
Certificate of deposits and time deposits	$	59,168	$	—	$	—	$	59,168
Commercial paper		—		2,000		—		2,000
U.S. treasuries		24,997		—		—		24,997
Total	$	84,165	$	2,000	$	—	$	86,165
Short-term investments
U.S. treasuries	$	149,219	$	—	$	—	$	149,219
Corporate debt		—		32,554		—		32,554
Commercial paper		—		7,998		—		7,998
Total	$	149,219	$	40,552	$	—	$	189,771

Schedule of amortized cost and fair value of available-for-sale securities

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2021
U.S. treasuries	$	118,801	$	9	$	(28)	$	118,782
Government agency securities		12,092		—		(6)		12,086
Corporate debt		67,689		28		(39)		67,678
Commercial paper		15,439		—		—		15,439
Total	$	214,021	$	37	$	(73)	$	213,985
December 31, 2020
U.S. treasuries	$	149,206	$	14	$	(1)	$	149,219
Corporate debt		32,588		—		(34)		32,554
Commercial paper		7,997		1		—		7,998
Total	$	189,791	$	15	$	(35)	$	189,771

Schedule of fair value and unrealized losses of available-for-sale securities in a loss position

	September 30, 2021				December 31, 2020
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	64,093	$	(28)	$	19,991	$	(1)
Government agency securities		12,086		(6)		—		—
Corporate debt		39,549		(39)		32,554		(34)
Total	$	115,728	$	(73)	$	52,545	$	(35)

Schedule of contractual maturities of securities classified as available-for-sale

	September 30, 2021
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	121,123	$	121,128
Due after one year through two years		87,080		87,037
Due after two years through three years		5,818		5,820
Total	$	214,021	$	213,985

Schedule of inventories

	September 30,		December 31,
	2021		2020
	(in thousands)
Materials	$	90,982	$	82,679
Work-in-process		64,134		53,979
Finished goods		15,719		9,248
Total	$	170,835	$	145,906

Schedule of property, plant, and equipment

	September 30,		December 31,
	2021		2020
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		63,944		62,865
Machinery and equipment (1)		144,937		140,493
Leasehold improvements		38,262		6,671
Gross property, plant, and equipment		252,204		215,090
Less: accumulated depreciation and amortization		158,353		149,819
Net property, plant, and equipment	$	93,851	$	65,271

(1) Machinery and equipment also includes software, furniture and fixtures

Schedule of intangible assets excluding goodwill

	September 30, 2021						December 31, 2020
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	308,587	$	19,321	$	327,908	$	302,358	$	25,550
Customer relationships		146,465		132,260		14,205		146,465		130,131		16,334
Trademarks and tradenames		30,910		27,556		3,354		30,910		26,614		4,296
Other		3,686		3,686		—		3,686		3,681		5
Total	$	508,969	$	472,089	$	36,880	$	508,969	$	462,784	$	46,185

XML

Liabilities (Tables)

9 Months Ended

Sep. 30, 2021

Liabilities

Schedule of accrued expenses and other current liabilities

	September 30,		December 31,
	2021		2020
	(in thousands)
Payroll and related benefits	$	33,868	$	26,630
Warranty		6,544		5,058
Operating lease liabilities		4,162		4,148
Interest		3,459		2,574
Professional fees		1,140		1,112
Legal settlement		15,000		—
Sales, use, and other taxes		6,092		2,658
Other		5,768		2,696
Total	$	76,033	$	44,876

Schedule of changes in product warranty reserves

		(in thousands)
Balance - December 31, 2020	$	5,058
Warranties issued		4,766
Consumption of reserves		(4,401)
Changes in estimate		1,121
Balance - September 30, 2021	$	6,544

Schedule of changes in deferred revenue

	(in thousands)
Balance - December 31, 2020	$	17,985
Deferral of revenue		7,008
Recognition of unearned revenue		(8,913)
Balance - September 30, 2021	$	16,080

Schedule of carrying value of Convertible Senior Notes

		September 30, 2021						December 31, 2020
		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	131,695	$	(7,754)	$	123,941	$	131,695	$	(11,925)	$	119,770
2025 Notes		132,500		(18,539)		113,961		132,500		(22,097)		110,403
2027 Notes		125,000		(31,025)		93,975		125,000		(34,058)		90,942
Net carrying value	$	389,195	$	(57,318)	$	331,877	$	389,195	$	(68,080)	$	321,115

Schedule of interest expense related to Convertible Senior Notes

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	889	$	1,733	$	2,667	$	6,060
Coupon interest expense - 2025 Notes		1,159		—		3,478		—
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		1,745
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		1,417		2,563		4,171		8,887
Amortization of debt discount/transaction costs- 2025 Notes		1,211		—		3,558		—
Amortization of debt discount/transaction costs- 2027 Notes		1,035		941		3,033		1,395
Total Interest Expense	$	6,883	$	6,409	$	20,423	$	18,087

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Schedule of maturities of lease liabilities 2020

The following table provides the maturities of lease liabilities at September 30, 2021:

	Operating
	Leases
	(in thousands)
Payments due by period:
2021	$	918
2022		4,679
2023		3,160
2024		2,914
2025		2,508
Thereafter		38,367
Total future minimum lease payments		52,546
Less: Imputed interest		(18,059)
Total	$	34,487
Reported as of September 30, 2021
Accrued expenses and other current liabilities	$	4,162
Long-term operating lease liabilities		30,325
Total	$	34,487

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2021

Stockholders' Equity

Schedule of Stockholders' Equity

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income (loss)	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income (loss)	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income, net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2019	48,994	$	490	$	1,071,058	$	(698,930)	$	1,894	$	374,512
Net income (loss)	—		—		—		(567)		—		(567)
Other comprehensive income (loss), net of tax	—		—		—		—		153		153
Share-based compensation expense	—		—		3,646		—		—		3,646
Net issuance under employee stock plans	434		4		(684)		—		—		(680)
Balance at March 31, 2020	49,428	$	494	$	1,074,020	$	(699,497)	$	2,047	$	377,064
Net income (loss)	—		—		—		(8,302)		—		(8,302)
Other comprehensive income (loss), net of tax	—		—		—		—		(130)		(130)
Share-based compensation expense	—		—		2,974		—		—		2,974
Net issuance under employee stock plans	191		2		753		—		—		755
Extinguishment of equity component of repurchased 2023 Notes	—		—		(80)		—		—		(80)
Equity component of 2027 Notes	—		—		33,363		—		—		33,363
Purchase of capped calls	—		—		(10,313)		—		—		(10,313)
Balance at June 30, 2020	49,619	$	496	$	1,100,717	$	(707,799)	$	1,917	$	395,331
Net income (loss)	—		—		—		580		—		580
Other comprehensive income, net of tax	—		—		—		—		(60)		(60)
Share-based compensation expense	—		—		2,942		—		—		2,942
Net issuance under employee stock plans	(7)		—		(700)		—		—		(700)
Balance at September 30, 2020	49,612	$	496	$	1,102,959	$	(707,219)	$	1,857	$	398,093

Schedule of the changes in the balances of each component of AOCI, net of tax

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2020		1,866		(20)		1,846
Other comprehensive income (loss)		(60)		(16)		(76)
Balance - September 30, 2021	$	1,806	$	(36)	$	1,770

XML

Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Compensation

Schedule of share-based compensation expense

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Cost of sales	$	620	$	389	$	1,765	$	1,384
Research and development		1,007		674		2,957		2,161
Selling, general, and administrative		2,504		1,879		7,013		6,017
Total	$	4,131	$	2,942	$	11,735	$	9,562

Summary of stock option activity

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2020	730		35.26
Expired or forfeited	(285)		40.19
Balance - September 30, 2021	445		32.11

Summary of non-vested restricted and performance shares activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2020	2,040		12.73
Granted	879		23.86
Performance award adjustments	(36)		19.75
Vested	(617)		13.84
Forfeited	(64)		14.36
Balance - September 30, 2021	2,202		16.70

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2021

Income Taxes

Schedule of loss before income taxes and income tax benefit

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Income (loss) before income taxes	$	9,404	$	791	$	18,864	$	(7,760)
Income tax expense (benefit)	$	411	$	211	$	1,029	$	530

XML

Segment Reporting and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting and Geographic Information

Schedule of sales by end-market

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Sales by end-market
Semiconductor	$	76,320	$	33,578	$	181,641	$	108,461
Compound Semiconductor		23,273		26,584		72,255		62,753
Data Storage		39,256		36,897		132,261		104,085
Scientific & Other		11,397		15,019		44,148		39,917
Total	$	150,246	$	112,078	$	430,305	$	315,216
Sales by geographic region
United States	$	48,776	$	39,602	$	160,908	$	108,869
EMEA(1)		13,564		14,991		36,128		57,271
China		27,261		10,464		68,148		38,328
Rest of APAC		60,589		46,953		164,926		110,328
Rest of World		56		68		195		420
Total	$	150,246	$	112,078	$	430,305	$	315,216

(1) EMEA consists of Europe, the Middle East, and Africa

Schedule of sales by geographic region

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
	(in thousands)
Sales by end-market
Semiconductor	$	76,320	$	33,578	$	181,641	$	108,461
Compound Semiconductor		23,273		26,584		72,255		62,753
Data Storage		39,256		36,897		132,261		104,085
Scientific & Other		11,397		15,019		44,148		39,917
Total	$	150,246	$	112,078	$	430,305	$	315,216
Sales by geographic region
United States	$	48,776	$	39,602	$	160,908	$	108,869
EMEA(1)		13,564		14,991		36,128		57,271
China		27,261		10,464		68,148		38,328
Rest of APAC		60,589		46,953		164,926		110,328
Rest of World		56		68		195		420
Total	$	150,246	$	112,078	$	430,305	$	315,216

(1) EMEA consists of Europe, the Middle East, and Africa

XML

Basis of Presentation - Fiscal Period (Details)	9 Months Ended
	Sep. 30, 2021
Basis of Presentation
Fiscal period duration (in days)	91 days

XML

Basis of Presentation - Revenue Recognition (Details)	9 Months Ended
	Sep. 30, 2021
Basis of Presentation
Revenue, practical expedient, incremental cost of obtaining contract	true

XML

Basis of Presentation - Recently Adopted Accounting Standards (Details)	Jan. 01, 2020
ASU 2019-12, Simplifying the Accounting for Income Taxes
Accounting Changes
Change in Accounting Principle, Accounting Standards Update, Adopted	true

XML

Income (Loss) Per Common Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income (Loss) Per Common Share
Net income (loss), Basic	$ 8,993	$ 580	$ 17,835	$ (8,290)
Net income (loss), Diluted	$ 8,993	$ 580	$ 17,835	$ (8,290)
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.18	$ 0.01	$ 0.36	$ (0.17)
Diluted (in dollars per share)	$ 0.17	$ 0.01	$ 0.33	$ (0.17)
Weighted average shares reconciliation
Basic weighted average shares outstanding	49,021	48,341	48,968	48,327
Dilutive effect of share-based awards	1,507	833	1,377
Dilutive effect of the 2027 Notes	3,321		3,261
Diluted weighted average shares outstanding	53,849	49,174	53,606	48,327

XML

Income (Loss) Per Common Share - Shares Excluded from EPS (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Common share equivalents
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive				650
Potentially dilutive shares
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	451	984	447	1,029
Convertible Notes
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	8,811	15,354	8,811	15,354

XML

Assets - Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Short-term investments
Transfer of assets from Level 1 to Level 2	$ 0
Transfer of assets from Level 2 to Level 1	0
Transfer of Liabilities from Level 1 to Level 2	0
Transfer of Liabilities from Level 2 to Level 1	0
Assets and liabilities measured on a recurring basis
Cash equivalents
Total Cash equivalents	56,427	$ 86,165
Short-term investments
Total Short-term investments	213,985	189,771
Assets and liabilities measured on a recurring basis | U.S. treasuries
Short-term investments
Total Short-term investments	118,782	149,219
Assets and liabilities measured on a recurring basis | Government agency securities
Short-term investments
Total Short-term investments	12,086
Assets and liabilities measured on a recurring basis | Corporate debt
Short-term investments
Total Short-term investments	67,678	32,554
Assets and liabilities measured on a recurring basis | Commercial paper
Short-term investments
Total Short-term investments	15,439	7,998
Assets and liabilities measured on a recurring basis | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	55,358	59,168
Assets and liabilities measured on a recurring basis | Commercial paper
Cash equivalents
Total Cash equivalents		2,000
Assets and liabilities measured on a recurring basis | Money market cash
Cash equivalents
Total Cash equivalents	1,069
Assets and liabilities measured on a recurring basis | U.S. treasuries
Cash equivalents
Total Cash equivalents		24,997
Assets and liabilities measured on a recurring basis | Level 1
Cash equivalents
Total Cash equivalents	56,427	84,165
Short-term investments
Total Short-term investments	118,782	149,219
Assets and liabilities measured on a recurring basis | Level 1 | U.S. treasuries
Short-term investments
Total Short-term investments	118,782	149,219
Assets and liabilities measured on a recurring basis | Level 1 | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	55,358	59,168
Assets and liabilities measured on a recurring basis | Level 1 | Money market cash
Cash equivalents
Total Cash equivalents	1,069
Assets and liabilities measured on a recurring basis | Level 1 | U.S. treasuries
Cash equivalents
Total Cash equivalents		24,997
Assets and liabilities measured on a recurring basis | Level 2
Cash equivalents
Total Cash equivalents		2,000
Short-term investments
Total Short-term investments	95,203	40,552
Assets and liabilities measured on a recurring basis | Level 2 | Government agency securities
Short-term investments
Total Short-term investments	12,086
Assets and liabilities measured on a recurring basis | Level 2 | Corporate debt
Short-term investments
Total Short-term investments	67,678	32,554
Assets and liabilities measured on a recurring basis | Level 2 | Commercial paper
Short-term investments
Total Short-term investments	$ 15,439	7,998
Assets and liabilities measured on a recurring basis | Level 2 | Commercial paper
Cash equivalents
Total Cash equivalents		$ 2,000

XML

Assets - Available-For-Sale Securities (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Total available-for-sale securities
Amortized Cost		$ 214,021	$ 189,791
Gross Unrealized Gains		37	15
Gross Unrealized Losses		(73)	(35)
Estimated Fair Value		213,985	189,771
Available-for-sale securities in a loss position
Estimated Fair Value		115,728	52,545
Gross Unrealized Losses		(73)	(35)
Investments that had been in a continuous loss position for more than 12 months		0	0
Contractual maturities - Amortized Cost
Amortized Cost, Due in one year or less		121,123
Amortized Cost, Due after one year through two years		87,080
Amortized Cost, Due after two years through three years		5,818
Amortized Cost		214,021	189,791
Contractual maturities - Estimated Fair Value
Estimated Fair Value, Due in one year or less		121,128
Estimated Fair Value, Due after one year through two years		87,037
Estimated Fair Value, Due after two years through three years		5,820
Available-for-sale Securities, Debt Securities, Total		213,985	189,771
Realized gains or losses
Realized gains	$ 0
Realized losses	$ 0
U.S. treasuries
Total available-for-sale securities
Amortized Cost		118,801	149,206
Gross Unrealized Gains		9	14
Gross Unrealized Losses		(28)	(1)
Estimated Fair Value		118,782	149,219
Available-for-sale securities in a loss position
Estimated Fair Value		64,093	19,991
Gross Unrealized Losses		(28)	(1)
Contractual maturities - Amortized Cost
Amortized Cost		118,801	149,206
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total		118,782	149,219
Government agency securities
Total available-for-sale securities
Amortized Cost		12,092
Gross Unrealized Losses		(6)
Estimated Fair Value		12,086
Available-for-sale securities in a loss position
Estimated Fair Value		12,086
Gross Unrealized Losses		(6)
Contractual maturities - Amortized Cost
Amortized Cost		12,092
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total		12,086
Corporate debt
Total available-for-sale securities
Amortized Cost		67,689	32,588
Gross Unrealized Gains		28
Gross Unrealized Losses		(39)	(34)
Estimated Fair Value		67,678	32,554
Available-for-sale securities in a loss position
Estimated Fair Value		39,549	32,554
Gross Unrealized Losses		(39)	(34)
Contractual maturities - Amortized Cost
Amortized Cost		67,689	32,588
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total		67,678	32,554
Commercial paper
Total available-for-sale securities
Amortized Cost		15,439	7,997
Gross Unrealized Gains			1
Estimated Fair Value		15,439	7,998
Contractual maturities - Amortized Cost
Amortized Cost		15,439	7,997
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total		$ 15,439	$ 7,998

XML

Assets - Accounts Receivable (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Assets
Allowance for doubtful accounts receivable	$ 0.7	$ 0.7

XML

Assets - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventories
Materials	$ 90,982	$ 82,679
Work-in-process	64,134	53,979
Finished goods	15,719	9,248
Total	$ 170,835	$ 145,906

XML

Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Prepaid expenses and other current assets
Current receivable for insurance recoveries related to legal settlement	$ 15.0
Current receivable for landlord reimbursement for leasehold improvements	1.1
Deposits with suppliers	$ 4.2	$ 7.2

XML

Assets - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, plant, and equipment
Gross property, plant and equipment	$ 252,204		$ 252,204		$ 215,090
Less: accumulated depreciation and amortization	158,353		158,353		149,819
Net property, plant, and equipment	93,851		93,851		65,271
Depreciation expense	3,500	$ 3,800	10,300	$ 11,500
Land
Property, plant, and equipment
Gross property, plant and equipment	5,061		5,061		5,061
Building and improvements
Property, plant, and equipment
Gross property, plant and equipment	63,944		63,944		62,865
Machinery and equipment
Property, plant, and equipment
Gross property, plant and equipment	144,937		144,937		140,493
Leaseholds improvements
Property, plant, and equipment
Gross property, plant and equipment	$ 38,262		$ 38,262		$ 6,671

XML

Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Intangible assets
Total Gross Intangible Assets	$ 508,969	$ 508,969
Accumulated Amortization and Impairment	472,089	462,784
Total Net Intangible Assets	36,880	46,185
Technology
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	327,908	327,908
Accumulated Amortization and Impairment, Definite-lived intangible assets	308,587	302,358
Total definite-lived intangible assets	19,321	25,550
Customer relationship
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	146,465	146,465
Accumulated Amortization and Impairment, Definite-lived intangible assets	132,260	130,131
Total definite-lived intangible assets	14,205	16,334
Trademarks and tradenames
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	30,910	30,910
Accumulated Amortization and Impairment, Definite-lived intangible assets	27,556	26,614
Total definite-lived intangible assets	3,354	4,296
Other Intangible Assets
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	3,686	3,686
Accumulated Amortization and Impairment, Definite-lived intangible assets	$ 3,686	3,681
Total definite-lived intangible assets		$ 5

XML

Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accrued expenses and other current liabilities
Payroll and related benefits	$ 33,868	$ 26,630
Warranty	6,544	5,058
Operating lease liabilities	4,162	4,148
Interest	3,459	2,574
Professional fees	1,140	1,112
Legal settlement	15,000
Sales, use, and other taxes	6,092	2,658
Other	5,768	2,696
Total	$ 76,033	$ 44,876

XML

Liabilities - Warranty (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Warranty
Warranty period	1 year
Balance, beginning of the period	$ 5,058
Warranties issued	4,766
Consumption of reserves	(4,401)
Changes in estimate	1,121
Balance, end of the period	$ 6,544

XML

Liabilities - Customer Deposits and Deferred Revenue (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Liabilities
Customer deposits and deferred revenue	$ 44,600	$ 49,300
Changes in deferred revenue
Beginning balance	17,985
Deferral of revenue	7,008
Recognition of unearned revenue	(8,913)
Ending balance	$ 16,080

XML

Liabilities - Performance Obligations Amount (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Performance obligations
Remaining performance obligations	$ 34.6
Minimum
Performance obligations
Performance obligation at time of contract origination	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Performance obligations
Percentage of remaining performance obligation expected to be recognized	73.00%

XML

Liabilities - Performance Obligations Timing (Details)	9 Months Ended
	Sep. 30, 2021
Liabilities
Revenue, Practical Expedient, Remaining Performance Obligation	true
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	2 years

XML

Liabilities - 2023, 2025 and 2027 Convertible Senior Notes (Details) - USD ($) $ in Thousands				9 Months Ended
	Nov. 11, 2020	May 18, 2020	Jan. 10, 2017	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Nov. 17, 2020
Debt
Principal amount					$ 389,195	$ 389,195
Proceeds, net of issuance costs				$ 121,946
Cash paid for repurchase of notes				81,240
Purchase of capped calls				$ 10,313
2023 Notes
Debt
Principal amount			$ 345,000		131,695	131,695
Interest rate (as a percent)			2.70%
Proceeds, net of issuance costs			$ 335,800
Repurchased and retired amount	$ 125,000	$ 88,300
Carrying amount of debt extinguished	$ 113,100	78,100
Cash paid for repurchase of notes		81,200
2025 Notes
Debt
Principal amount					132,500	132,500	$ 132,500
Interest rate (as a percent)							3.50%
2027 Notes
Debt
Principal amount		$ 125,000			$ 125,000	$ 125,000
Interest rate (as a percent)		3.75%
Proceeds, net of issuance costs		$ 121,900
Purchase of capped calls		$ 10,300

XML

Liabilities - Convertible Senior Notes (Details)					3 Months Ended	9 Months Ended
	Nov. 17, 2020 USD ($) $ / shares	May 18, 2020 USD ($) $ / shares	May 13, 2020 USD ($) $ / shares	Jan. 10, 2017 USD ($) $ / shares	Sep. 30, 2021 D	Sep. 30, 2021 USD ($) D
Capped Call Transactions
Debt
Aggregate price of capped call transaction			$ 10,300,000
Cap price of the capped call transactions (in dollars per share) | $ / shares			$ 18.46
Convertible Notes
Debt
Multiples of principal holders may convert						1,000
Minimum threshold period | D						20
Consecutive trading days | D					30	30
Stock price trigger (as a percent)					130.00%	130.00%
Trading days | D						5
Number of consecutive business days						5 days
Maximum percentage of common stock conversion						98.00%
2023 Notes
Debt
Conversion rate				0.0249800
Conversion price (in dollars per share) | $ / shares				$ 40.03
Measurement input				0.070
Long-term Debt, Measurement Input				us-gaap:MeasurementInputDiscountRateMember
Debt discount				$ 72,500,000
Transaction costs				9,200,000
Transaction costs allocated to the equity component				$ 1,900,000
2025 Notes
Debt
Conversion rate	0.0416667
Conversion price (in dollars per share) | $ / shares	$ 24.00
Measurement input	0.080
Long-term Debt, Measurement Input	us-gaap:MeasurementInputDiscountRateMember
Debt discount	$ 21,000,000.0
Transaction costs	1,900,000
Transaction costs allocated to the equity component	$ 300,000
2027 Notes
Debt
Conversion rate		0.0715372
Conversion price (in dollars per share) | $ / shares		$ 13.98
Measurement input		0.091
Long-term Debt, Measurement Input		us-gaap:MeasurementInputDiscountRateMember
Debt discount		$ 34,200,000
Transaction costs		3,100,000
Transaction costs allocated to the equity component		$ 800,000

XML

Liabilities - Convertible Senior Notes Carrying Value (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Nov. 17, 2020	May 18, 2020	Jan. 10, 2017
Debt
Principal amount	$ 389,195	$ 389,195
Unamortized debt discount/transaction costs	(57,318)	(68,080)
Net carrying value	331,877	321,115
2023 Notes
Debt
Principal amount	131,695	131,695			$ 345,000
Unamortized debt discount/transaction costs	(7,754)	(11,925)
Net carrying value	123,941	119,770
2025 Notes
Debt
Principal amount	132,500	132,500	$ 132,500
Unamortized debt discount/transaction costs	(18,539)	(22,097)
Net carrying value	113,961	110,403
2027 Notes
Debt
Principal amount	125,000	125,000		$ 125,000
Unamortized debt discount/transaction costs	(31,025)	(34,058)
Net carrying value	$ 93,975	$ 90,942

XML

Liabilities - Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Non-Cash Interest Expense
Amortization of debt discount/transaction costs			$ 10,762	$ 10,282
Total Interest Expense	$ 6,883	$ 6,409	20,423	18,087
2023 Notes
Cash Interest Expense
Coupon interest expense	889	1,733	2,667	6,060
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 1,417	2,563	$ 4,171	8,887
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 132,600		$ 132,600
2025 Notes
Cash Interest Expense
Coupon interest expense	1,159		3,478
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 1,211		$ 3,558
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 158,200		$ 158,200
2027 Notes
Cash Interest Expense
Coupon interest expense	1,172	1,172	3,516	1,745
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 1,035	$ 941	$ 3,033	$ 1,395
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 223,900		$ 223,900

XML

Liabilities - Other Liabilities (Details) - USD ($) $ in Millions	54 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Other liabilities
Contributions to deferred compensation plan	$ 0.0
Accrued and deferred deposit payments	3.5	$ 3.5
Other Assets
Other liabilities
Deferred compensation plan assets		2.4
Accrued expenses and other current liabilities
Other liabilities
Accrued and deferred deposit payments	1.7	1.7
Other Liabilities
Other liabilities
Deferred compensation plan liabilities		2.5
Medical and dental benefits	1.8	1.9
Asset retirement obligations	2.8	2.7
Income taxes payable	1.4	1.4
Accrued and deferred deposit payments	$ 1.8	$ 1.8

XML

Commitments and Contingencies - Lease terms (Details)	Sep. 30, 2021
Leases
Lease renewal term	5 years
Remaining lease term	13 years
Weighted average discount rate (as a percent)	5.60%

XML

Commitments and Contingencies - Minimum lease commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Minimum lease commitments, Payments due by period:
2021	$ 918
2022	4,679
2023	3,160
2024	2,914
2025	2,508
Thereafter	38,367
Total future minimum lease payments	52,546
Less: Imputed interest	(18,059)
Total operating lease liabilities	34,487
Operating lease liability, current	$ 4,162	$ 4,148
Operating Lease, Liability, Current, Statement of Financial Position	Accrued expenses and other current liabilities
Long-term operating lease liabilities	$ 30,325	$ 6,305
Total operating lease liabilities	$ 34,487
Operating Lease, Liability, Statement of Financial Position	Long-term operating lease liabilities, Accrued expenses and other current liabilities

XML

Commitments and Contingencies - Lease costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lease cost
Operating lease cost	$ 1.8	$ 1.3	$ 4.8	$ 4.1
Variable lease cost	$ 0.4	$ 0.4	1.3	1.3
Operating cash flows from operating leases			$ 4.9	$ 4.8

XML

Commitments and Contingencies - Purchase Commitments and Bank Guarantees (Details) $ in Millions	Sep. 30, 2021 USD ($)
Purchase commitments
Purchase commitments due within one year	$ 141.6
Bank guarantees
Bank guarantees and letters of credit outstanding	5.4
Unused bank guarantees and letters of credit	$ 16.7

XML

Commitments and Contingencies - Legal Proceedings (Details) $ in Millions		1 Months Ended
	Aug. 08, 2018 case	Oct. 31, 2021 USD ($)
Ultratech acquisition litigation
Legal Proceedings
Number of purported class action complaints filed | case	2
Wolther Action | Subsequent event
Legal Proceedings
Settlement amount | $		$ 15.0

XML

Equity - Statement of Stockholders' Equity (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 423,735	$ 412,461	$ 408,374	$ 395,331	$ 377,064	$ 374,512	$ 408,374	$ 374,512
Net income (loss)	8,993	6,348	2,494	580	(8,302)	(567)	17,835	(8,290)
Other comprehensive income (loss), net of tax	(33)	(24)	(19)	(60)	(130)	153
Share-based compensation expense	4,131	4,367	3,237	2,942	2,974	3,646
Net issuance under employee stock plans	(1,513)	583	(1,625)	(700)	755	(680)
Extinguishment of equity component of repurchased/exchanged 2023 Notes					(80)
Equity component of Notes					33,363
Purchase of capped calls					(10,313)
Balance at the end of the period	435,313	423,735	412,461	398,093	395,331	377,064	435,313	398,093
Common Stock
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 503	$ 502	$ 497	$ 496	$ 494	$ 490	$ 497	$ 490
Balance (in shares)	50,349	50,183	49,724	49,619	49,428	48,994	49,724	48,994
Net issuance under employee stock plans		$ 1	$ 5		$ 2	$ 4
Net issuance under employee stock plans (in shares)	(28)	166	459	(7)	191	434
Balance at the end of the period	$ 503	$ 503	$ 502	$ 496	$ 496	$ 494	$ 503	$ 496
Balance (in shares)	50,321	50,349	50,183	49,612	49,619	49,428	50,321	49,612
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 1,119,908	$ 1,114,959	$ 1,113,352	$ 1,100,717	$ 1,074,020	$ 1,071,058	$ 1,113,352	$ 1,071,058
Share-based compensation expense	4,131	4,367	3,237	2,942	2,974	3,646
Net issuance under employee stock plans	(1,513)	582	(1,630)	(700)	753	(684)
Extinguishment of equity component of repurchased/exchanged 2023 Notes					(80)
Equity component of Notes					33,363
Purchase of capped calls					(10,313)
Balance at the end of the period	1,122,526	1,119,908	1,114,959	1,102,959	1,100,717	1,074,020	1,122,526	1,102,959
Retained Earnings
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	(698,479)	(704,827)	(707,321)	(707,799)	(699,497)	(698,930)	(707,321)	(698,930)
Net income (loss)	8,993	6,348	2,494	580	(8,302)	(567)
Balance at the end of the period	(689,486)	(698,479)	(704,827)	(707,219)	(707,799)	(699,497)	(689,486)	(707,219)
Accumulated Other Comprehensive Income
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	1,803	1,827	1,846	1,917	2,047	1,894	1,846	1,894
Other comprehensive income (loss), net of tax	(33)	(24)	(19)	(60)	(130)	153
Balance at the end of the period	$ 1,770	$ 1,803	$ 1,827	$ 1,857	$ 1,917	$ 2,047	$ 1,770	$ 1,857

XML

Equity - AOCI Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Changes in the balances of each component of AOCI
Balance at the beginning of the period	$ 423,735	$ 395,331	$ 408,374	$ 374,512
Other comprehensive income (loss)	(33)	(60)	(76)	(37)
Balance at the end of the period	435,313	398,093	435,313	398,093
Accumulated Other Comprehensive Income
Changes in the balances of each component of AOCI
Balance at the beginning of the period	1,803	1,917	1,846	1,894
Other comprehensive income (loss)			(76)
Balance at the end of the period	1,770	$ 1,857	1,770	$ 1,857
Translation adjustment
Changes in the balances of each component of AOCI
Balance at the beginning of the period			1,866
Other comprehensive income (loss)			(60)
Balance at the end of the period	1,806		1,806
Unrealized gain on available for sale securities
Changes in the balances of each component of AOCI
Balance at the beginning of the period			(20)
Other comprehensive income (loss)			(16)
Balance at the end of the period	$ (36)		$ (36)

XML

Share-based Compensations - Recognized Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Recognized share-based compensation
Total share-based compensation expense	$ 4,131	$ 2,942	$ 11,735	$ 9,562
Cost of Sales
Recognized share-based compensation
Total share-based compensation expense	620	389	1,765	1,384
Research and Development Expense
Recognized share-based compensation
Total share-based compensation expense	1,007	674	2,957	2,161
Selling, General and Administrative Expenses
Recognized share-based compensation
Total share-based compensation expense	$ 2,504	$ 1,879	$ 7,013	$ 6,017
Restricted Stock Awards | Minimum
Share-based compensation
Expiration term			1 year
Restricted Stock Awards | Maximum
Share-based compensation
Expiration term			5 years

XML

Share-based Compensation - Stock Option Activity (Details) - Stock options shares in Thousands	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	730
Expired or forfeited (in shares) | shares	(285)
Outstanding at the end of the period (in shares) | shares	445
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 35.26
Expired or forfeited (in dollars per share) | $ / shares	40.19
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 32.11

XML

Share-based Compensation - Restricted shares and performance shares (Details) - Non-vested restricted shares and performance shares shares in Thousands	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	2,040
Granted (in shares) | shares	879
Performance award adjustments (in shares) | shares	(36)
Vested (in shares) | shares	(617)
Forfeited (in shares) | shares	(64)
Outstanding at the end of the period (in shares) | shares	2,202
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 12.73
Granted (in dollars per share) | $ / shares	23.86
Performance award adjustments (in dollars per share) | $ / shares	19.75
Vested (in dollars per share) | $ / shares	13.84
Forfeited (in dollars per share) | $ / shares	14.36
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 16.70

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Tax reconciliation disclosures
Income (loss) before income taxes	$ 9,404	$ 791	$ 18,864	$ (7,760)
Income tax expense (benefit)	411	211	1,029	530
Federal
Tax reconciliation disclosures
Income tax expense (benefit)			200	200
Foreign tax
Tax reconciliation disclosures
Income tax expense (benefit)	$ 400	$ 200	$ 800	$ 300

XML

Segment Reporting and Geographic Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) segment item	Sep. 30, 2020 USD ($)
Revenue reporting by end-market and geographic region
Number of operating segments | segment			1
Number of reportable segments | segment			1
Number of key markets | item			4
Sales	$ 150,246	$ 112,078	$ 430,305	$ 315,216
United States
Revenue reporting by end-market and geographic region
Sales	48,776	39,602	160,908	108,869
EMEA
Revenue reporting by end-market and geographic region
Sales	13,564	14,991	36,128	57,271
China
Revenue reporting by end-market and geographic region
Sales	27,261	10,464	68,148	38,328
Rest of APAC
Revenue reporting by end-market and geographic region
Sales	60,589	46,953	164,926	110,328
Rest Of World
Revenue reporting by end-market and geographic region
Sales	56	68	195	420
Semiconductor
Revenue reporting by end-market and geographic region
Sales	76,320	33,578	181,641	108,461
Compound Semiconductor
Revenue reporting by end-market and geographic region
Sales	23,273	26,584	72,255	62,753
Data Storage
Revenue reporting by end-market and geographic region
Sales	39,256	36,897	132,261	104,085
Scientific & Other
Revenue reporting by end-market and geographic region
Sales	$ 11,397	$ 15,019	$ 44,148	$ 39,917